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ABSTRACT 
 
Background.  This cohort study investigates whether there are inequities in the 
allocation of cadaver kidneys for preemptive kidney transplants (PKT) between blacks and 
whites. 
 Methods.  This analysis uses descriptive statistics and univariate and multivariate 
analyses to identify factors associated with the determination of whether a patient receives a 
PKT or a conventional, post dialysis kidney transplant.  The sample includes patients 
identified by the Centers for Medicare and Medicaid Services (CMS) as having end stage 
renal disease (ESRD), >19 years of age, either black or white, and receiving either a PKT (0-
<6 months dialysis) or conventional transplant between January 1, 2000 and December 31, 
2003 (n = 10,067) from any of the 11 organ procurement regions in the United States.     
Results.   Whites were more likely to receive a PKT (p<0.05). Females were 23% 
more likely to receive a preemptive kidney transplant as males.  Those without hypertension 
as the primary cause of ESRD were more than 3 times more likely to receive a PKT. Those 
without diabetes as the primary cause of ESRD were as than 2 times more likely to receive a 
PKT.  Those without glomerulonephritis as the primary cause of ESRD were more than 2 
times as likely to receive a PKT.  Interestingly, this research shows that the leading causes of 
ESRD in blacks and whites who received PKTs was diabetes, 22% and 31% respectively. 
Black conventional transplant recipients had higher rates of hypertension and diabetes than 
did black PKT recipients overall. White conventional kidney transplant recipients had the 
highest rates of diabetes (39.19%) of all groups. Of all PKT recipients, blacks received 
10.76% compared with 89.24% received by whites. The mean age for blacks receiving PKTs 
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was 48.4 years of age compared with 47 years of age for black conventional kidney 
transplant recipients. The mean age for whites, both PKT and conventional transplant 
recipients was approximately 49 years of age. Higher percentages of PKTs took place in the 
northeastern and southeastern regions (UNOS regions 2 and 3) of the United States.  The 
majority of PKT recipients, both blacks and whites, received their donor organs from whites.  
Blacks received 69.42% white donor, organs compared with 77.61% received by whites.  
Blacks did receive 17.43% of their donor organs from blacks, with whites receiving 
approximately 6% of their organs from blacks. For those receiving PKTs during the study 
period, 86% of whites and 81% of blacks were still alive with functioning grafts at the 
conclusion of the study period.  Medicare A and B as the primary insurance and those who 
had Medicare as a secondary payer each did reflect statistical significance as indicators of 
being less likely than patients insured otherwise.   
 Conclusion. From this analysis it is concluded that a disparity exists in the allocation 
of PKTs between blacks and whites.  These results indicate that blacks are less likely to 
receive a PKT than their white ESRD counterparts, females are more likely to receive a 
preemptive kidney transplant than males, and that both males and females are more likely to 
receive a PKT if they do not have a diagnosis as the primary cause of their ESRD of 
hypertension, diabetes and/or glomerulonephritis.    These results suggest that there may be 
remediable inequities in the current system relating to the policies of UNOS and that PKTs 
can be allocated in a more equitable manner.      
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CHAPTER  1.  INTRODUCTION 
 
 
 The first successful kidney transplant performed by Dr. Joseph Murray took place 
over 50 years ago.  Subsequently, the field of kidney transplantation has continued to evolve, 
and long-term survival following transplantation has surpassed survival on dialysis for all 
races (Wolf, et al., 1999).  Renal transplantation reduces mortality, improves quality of life, 
and is less costly than dialysis (Kasiske, et al., 2000).  The benefits of kidney transplantation 
have been shown regardless of recipient sex, race, age, or cause of end stage renal disease 
(ESRD) (Wolf et al., 1999). The benefits of preemptive kidney transplantation (PKT) have 
shown it to be the optimal strategy to benefit patients requiring renal replacement therapy 
(Wolf, et al., 1999). Although both blacks and whites have benefited from these advances, it 
remains unfortunate that use of these life-prolonging modalities is not equivalent among all 
races; also equivalent success eludes blacks who are disadvantaged in gaining kidney 
transplants.  Constituting almost half of those waiting for a renal transplant, blacks receive 
less than 28% of all cadaver-donor kidneys each year and an even smaller percentage of PKT 
before the initiation of maintenance dialysis (Young & Kew, 2005). 
 Kidney transplantation has historically taken place after a variable period of dialysis 
therapy.  The optimal timing of kidney transplantation and the question of whether one 
receives a transplant preemptively or begins routine dialysis maintenance is the subject of 
much controversy (Katz et al., 1991; Roake et al., 1996).  The debate regarding preemptive 
kidney transplantation (PKT) is compounded by the fact that first of all it takes place 
contrary to the policies outlined by the United Network for Organ Sharing and secondly it is 
hypothesized by this research that since blacks have not historically enjoyed the benefits of 
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conventional renal transplantation to the same degree as their white counterparts (Norris & 
Agodoa, 2005) they most certainly do not enjoy the relative frequency of PKT as do their 
white counterparts.  Because blacks are much less likely than whites to be referred for 
evaluation at a transplant center, to be placed on a waiting list, or to receive traditional post-
dialysis transplants (Ayanian et al., 1999), it logically follows that their use of PKT would be 
limited as well.  Given the disparities blacks have experienced with renal replacement and 
the benefits attributed to PKT, the question remains whether blacks will fare any better in the 
PKT arena when compared with their white counterparts.  The current analysis of data 
obtained from the United Network for Organ Sharing (UNOS) and United States Renal Data 
system (USRDS) examined the characteristics of patients who received either PKT or 
conventional transplants, the effect of PKT or conventional transplants on outcomes, whether 
the effects on outcomes were similar in both PKT and conventional transplant patients and 
whether these effects were independent of recipients race and/or other factors.  
 
BLACKS AND ESRD 
 To create a context for the current study’s examination of the disparity in PKT, brief 
overviews are provided of the end stage renal disease (ESRD) problem and how blacks now 
have such a significant need for transplantation.  Chronic kidney disease (CKD) occurs when 
the kidneys begin to fail in their ability to excrete wastes, concentrate urine, and regulate 
electrolytes.  The National Kidney Foundation (NKF) estimates that 20 million Americans 
have CKD, and at least 20 million others are at increased risk to develop CKD.  End stage 
renal disease (ESRD) occurs when the kidneys are no longer able to function at a level 
necessary for day-to- day life, which is usually when kidney function drops below 10% of 
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normal functioning capacity.  During the last decade, the number of ESRD patients in the 
United States grew at an exponential rate—doubling from 201,454 in 1991 to 406,081 in 
2001 (Norris & Agodoa, 2005).  There was a 4.2% increase in the ESRD population between 
2000 and 2001 (Szczech & Lazar, 2004).  There are projections that the ESRD population 
will increase to 700,000 by 2010 and to more than 2 million people by 2030 (Szczech & 
Lazar, 2004).   
A review of recent data indicates that ESRD occurs nearly four times more frequently 
among blacks than their white counterparts, and continues to represent one of the most 
dramatic examples of health disparities in our nation (Norris & Agodoa, 2002).  The black 
population consistently has suffered from a greater than 3.5-fold higher rate of treated ESRD 
than the white population.  The United States Renal Data System (USRDS) annual report 
from 2004 noted that blacks in the United States continued to have a disproportionately 
greater incidence and prevalence rate of ESRD (Fig. 1-1) (Agodoa, 2003).  The overall 
adjusted incidence rate of new black ESRD patients in 2003 was 998 per million population, 
compared with 334 per million for whites.  This represented a quadrupling of the overall 
incidence of ESRD since 1980 (USRDS, 2003).   
Correspondingly, the ESRD program has a significant over-representation of blacks.  
Although some factors contributing to these alarming rates of ESRD among blacks have been 
identified, the exact reasons why these disparities exist have yet to be fully elucidated.    
Despite concerted efforts to better understand the causative factors that precipitate renal 
disease in blacks, ESRD in the U.S. is likely to remain disproportionately higher in blacks.   
As a result, blacks will continue to disproportionately populate dialysis centers and transplant  
 
center waiting lists. 
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Figure 1-1.  Incidence rates of ESRD due to diabetes, hypertension, and other renal 
disease according to ethnicity.  
 
Source:  Agodoa L. Lessons from chronic renal diseases in African Americans: Treatment 
implications. Ethn Dis 2003;13:S120.  Reprinted with permission. 
 
 
 
DIABETES MELLITUS 
 Approximately 70% of all new adult ESRD cases in the United States are attributable 
to diabetes and hypertension.  Diabetes is the leading cause of ESRD, with 
glomerulonephritis and cystic kidney diseases constituting about 10% of cases (see Fig. 1-1) 
(Agodoa, 2003).  The prevalence of diabetes in black men is nearly 50% greater than in white 
men, and black women are 100% more likely to have diabetes than white women (Crook et 
al., 2001).  An estimated (NHANES III, 1988-1994) 8% of adults in the United States have 
type 2 diabetes mellitus (Harris, 1998), and the incidence of this disease is increasing 
(USRDS, 2003). The number of cases of diabetes mellitus, and consequently diabetic 
nephropathy, is also rising progressively worldwide (King, 1998). Diabetic nephropathy 
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occurs in about one third of patients with diabetes mellitus and is the most common cause of 
ESRD in most industrialized nations—accounting for nearly half of new ESRD cases 
(USRDS, 2003). Relative to whites, the incidence of diabetes mellitus is 2.3 times higher in 
blacks than whites (USRDS, 2003).  
 Krop et al. (1999) noted that blacks with diabetes mellitus had early renal function 
decline three times that of whites.  More than 80% of this disparity has been attributed to 
lower socioeconomic status, suboptimal health behaviors, and suboptimal control of blood 
glucose level and blood pressure.  This trend is likely to continue because the incidence of 
type 2 diabetes mellitus is fueled by the increasing prevalence of obesity among blacks. 
 
HYPERTENSION 
 The second most common cause of ESRD is hypertension.  The prevalence of 
hypertension among blacks in the United States has increased substantially and is the highest 
in the world (Coresh et al., 2001).  Among young blacks aged 20 to 44 years, the incidence of 
hypertension is 20 times higher than that of whites (USRDS 2001, Annual Report).  The age 
adjusted prevalence of hypertension in blacks is 32.4%, which is nearly 40% higher than 
whites (23%) (Burt et al., 1995).  The pattern of hypertensive ESRD is unique among blacks; 
it has remained a leading cause of ESRD for all ages, from the pediatric group—which is 
uncommon in other racial/ethnic groups—through the geriatric black population (Agodoa, 
2003).  Among several theories that have been proposed to explain the significant 
hypertensive rates among blacks is the possibility that environmental and genetic factors 
(excess salt intake superimposed on a genetic predisposition to salt retention) may lead to 
low-renin hypertension (Warnock, 2000).  Blacks may have a predisposition to the 
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deleterious effects of hypertension on renal function, even if blood pressures are well 
controlled (Hall et al., 1997).  Added to these physiologic variables are the socioeconomic 
and educational disadvantages often encountered by blacks, many of whom never received 
care for their hypertension before developing irreversible kidney failure (Geiger, 1996).  
Hypertension is a major contributing factor in the increased prevalence of ESRD seen in the 
black population, leading to dialysis or transplantation (UNOS 1999, Annual Report).  In 
sum, there are proportionately more blacks entering the ESRD network; yet, as a group, they 
are significantly under-represented in the population receiving renal transplants (Young & 
Kew, 2005). 
 Although diabetes, hypertension, and some of the other factors contributing to the 
alarming rates of ESRD among blacks have been identified, the reasons for the disparities in 
transplantation rates between blacks and whites have yet to be fully explained. For the time 
being it appears that ESRD is likely to remain disproportionately higher in blacks and, 
therefore, result in many more blacks remaining on dialysis and awaiting kidney transplants. 
 
DIALYSIS 
 A disproportionate number of black patients receive hemodialysis as the treatment 
modality for renal replacement therapy.  Data from the USRDS in 1999 revealed that black 
patients had the highest incidence of hemodialysis among all racial or ethnic populations 
(Gadegbeku, Freeman & Lawrence, 2002).  Although dialysis is life prolonging, extended 
periods on dialysis are detrimental to subsequent renal allograft survival. Furthermore, late or 
emergency referral to dialysis, which is associated with three-fold higher mortality and 
morbidity rates, longer and more expensive hospital stays (Roubicek, Brunet & Huiart, 
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2000), is more likely to occur in blacks than whites.  Lower levels of kidney function at 
initiation of dialysis appear to a greater extent in blacks than in other racial groups (Kausz et 
al., 2000).   Even when dialysis is undertaken, despite the clear guidelines for hemodialysis 
dose and monitoring, the prescribed dose is more likely to be suboptimal in black 
hemodialysis patients (Owen et al., 1998). 
 Because of the increasing incidence and prevalence of ESRD there is an ever 
increasing shortage of kidneys for transplantation.  As a result of this shortage combined with 
additional pathophysiological factors, blacks are less likely to receive a transplanted kidney 
than are their white counterparts.  This diminished likelihood of receiving a transplant has 
been linked to nephrologists’ delaying referral of blacks for transplantation and the 
diminished likelihood of their being placed on the UNOS waiting list (Roizon-Solomon & 
Burrows, 1999).  As a result, most blacks with ESRD receive hemodialysis to perform the 
work of their diseased kidneys.   
 Despite the hefty representation of blacks on hemodialysis, the annual death rate was 
181/100 patient years, lower than the 284.7/1000 patient years for whites (USRDS, 2002).  
The lower rate has been attributed to blacks fairing better than whites on dialysis; however, 
this conclusion may be incorrect.  Because blacks on hemodialysis tend to be younger, a 
possible explanation for this difference in death rats is that blacks on dialysis are healthier 
than whites on dialysis and are better able to withstand dialysis treatment.  In 2002, 54% of 
patients on dialysis under age 50 years old were black; this percentage decreased to 39% for 
those over age 50 years (USRDS, 2002).  It follows that blacks who are suitable candidates 
for renal transplantation are not being transplanted but are waiting on dialysis.  Conversely, 
the older, less healthy, and more likely un-transplantable patients (older whites with co-
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morbidities) are dying on dialysis and possibly creating the false impression that death rates 
are higher.  Between 1997 and 2000, 49,963 cadaver donor renal transplants took place in the 
United States (Young & Kew, 2005).  Of these allograft, 35,532 (71%) were transplanted 
into whites, whereas 11,667 (23%) went to blacks.  Therefore, it was surmised that the 
decrease in the proportion of whites in the prevalent population was mainly due to their 
referral for renal transplantation and not patient death (Agodoa, 2003). 
 
TRANSPLANTATION AND HLA MATCHING 
 On December 23, 1954, the first successful human organ transplant was performed.  
A kidney was transplanted from a living donor who was an identical twin of the recipient.  
Because immunosuppressive therapy had not evolved to its current state, there was no 
consideration given to the use of cadaver organs.  The burden for finding a suitable living 
donor rested with those in need of organs.  There was no waiting list and no apparent 
shortage of organs (Barnett & Kaserman, 2000).  Not long after the first successful 
transplant, improved tissue matching made transplantation of cadaver kidneys possible.  In 
1972 the ESRD program, which was administered by the Social Security Administration, 
extended federal insurance coverage to kidney transplantation and dramatically increased the 
demand for cadaver organs.  This change led to a shift in kidney procurement policy, from 
focusing exclusively upon living related donors to the procurement of cadaver organs from 
unrelated donors.  The kidney transplant waiting list managed by health professionals at local 
transplant centers, began to form in the late 1970s putting pressure on scientists to find ways 
to alleviate the shortage of transplantable kidneys.  Given the predominantly white donor 
population in the United States, black ESRD patients were at an obvious disadvantage in 
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their chances of receiving a suitable kidney. This situation was and continues to be 
compounded by lower levels of organ donation among blacks due, at least in part, to many 
cultural factors (Epstein et al., 2000).  
 Research shows that blacks are less likely than white patients to be considered 
appropriate candidates for transplantation (9% versus 21%, respectively) and that blacks 
continue to be more likely to have an incomplete transplant workup (47% versus 39%) 
(Epstein et al., 2000). The most common reasons offered for blacks being considered 
inappropriate for transplantation were a body mass index over 35, presence of an active 
infection and presence of extra-renal, non-cardiac co-morbidities. Even after candidacy is 
established among patients considered suitable for a transplant, blacks still remain at a 
disadvantage and are still less likely than whites to actually receive a transplant (17% vs. 
52%, respectively) (Epstein et al., 2000).   
 The United Network for Organ Sharing (UNOS) allocation policy mandates ABO 
blood type identity.  Although this is a necessary policy, black candidates, by nature 
of the donor pool (predominantly white), are disadvantaged by a predilection for ABO  
 
blood types associated with longer waits (Epstein et al., 2000).  Another important facet in 
determining who receives a kidney transplant is the relative weight given the anti-major 
histocompatibility complex (MHC) matching in the former UNOS allocation algorithm 
(Table 1-1). Wait-listed transplant candidates accumulate ‘‘points.’’  When a kidney  
becomes available, the medically suitable candidate with the most  points is designated to  
receive the organ. Based on the assumption that similarity in MHC antigen expression (i.e., 
matching) between donor and recipient optimizes outcomes, matching was the predominant 
variable determining allocation of deceased-donor kidneys (Norman, 1995).  The primary  
  10 
 
Table 1-1. Former renal allocation point system for allocating cadaver kidneys in the 
United States. 
 
Criterion  
Points 
Awarded 
Zero antigen mismatch mandatory share
MHC mismatches  
  0 BDR  7 
  1 BDR  5 
  2 BDR  2 
Presensitization  
  Panel reactive antibody ? 80% 4 
Waiting time  
  Longest wait (then fractional) 1 
  Each year on list 1 
Age   
  <11 y  4 
  11-18 y  3 
 
 
Source:  Young, C.J., Kew C. Health disparities in transplantation: focus on the complexity 
and challenge of renal transplantation in African Americans. Med Clin N Am 2005; 89:1003-
31. 
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benefit of this allocation algorithm was unintentionally conferred on the predominantly white 
recipients of completely matched grafts, with marginal impact on outcomes across other 
match grades, especially among black recipients. This trend was recognized over a decade 
ago with few inter-racial transplants occurring with greater than three (of six) matched MHC 
alleles (Lazda, 1992).  
Takemoto et al. (2000) reviewed the UNOS database from 1987 to September 1999 
under the UNOS allocation algorithm to determine the efficacy of sharing HLA matched 
kidneys.  Although blacks benefited from this sharing, they received only 8% of the 7,614 
matched kidneys. Conversely, 30% of mismatched kidneys went to blacks, approximating the 
frequency with which blacks appeared on the wait list (Scantlebury et al., 1998).  Even the 
proponents of the former allocation system conceded that racial disparity existed (Takemoto 
et al., 2000).  This fact was made more unacceptable when improved immunosuppressive 
medications reduced the impact of matching on allograft survival (Cecka, 1999).  The core of 
the former point system was implemented in the 1980s when demonstrable incremental 
benefit of improved HLA compatibility between donor and recipient was evident. Now, at 
least two groups of investigators estimate that the overall benefit of improved HLA 
compatibility between donor and recipient is relatively small, improving graft survival by 
only 1%–2% (Held et al., 1994; Feldman et al., 1997).   
In addition, early reports documented no statistical benefit of matching among blacks, 
a finding attributed to the difficulty of obtaining enough good matches in this population for 
meaningful analysis (Takemoto et al., 1994). Current data indicate a benefit for blacks of 
5%–6% (in graft survival at 3 years) in the few patients able to receive completely matched 
grafts, and improvement in allograft half-life from 5.4 to 8.4 years (the latter still being less 
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than the years expected for white recipients of mismatched kidneys) (Scantlebury et al., 
1998). 
A new UNOS renal allocation scheme was implemented in May 2003 to address 
discrepancies in kidney allocation that result from a heterogeneous HLA donor and recipient 
population (Table 1-2). Implementation of this new scheme has been an important step in 
rectifying the disparity in allocation of kidney transplants among black and white transplant 
candidates.  Inasmuch as the former UNOS algorithm perpetuated ethnic disparities, major 
changes have occurred while preserving mandatory sharing of phenotypically identical 
(completely matched) kidneys because it improves transplant outcomes and, despite 
identifiable adverse impact on access for blacks, removes relatively few organs from the 
overall pool (Young & Kew, 2005). 
Beyond phenotypic identity, allocation of points for ‘‘partial’’ matching was 
determined indefensible. A 1995 analysis confirmed that ‘‘matching points’’ were 
accumulated disproportionately by whites and awarded for match quality that produced 
outcomes no better (two mismatches) or worse (three mismatches) than the national average 
(Meier-Kriesche, et al., 2000).  In response, the algorithm was modified to its current form.  
The impact of these modifications on access for blacks is being assessed (Young & Kew, 
2005).  A recent regional study involving the New England Organ Bank documented that 
elimination of points for partial matching indeed improved access for blacks without 
compromising outcomes (Delmonico, et al., 1999). Other modifications are possible.  
 Currently, UNOS allows local variances based on the concept of acceptable 
mismatches that preserve the benefits of matching while offering more equitable allocation.  
Although some investigators remain unenthusiastic about the potential benefit of such an  
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Table 1-2. Current United Network for Organ Sharing Organ Allocation Point 
System for allocating cadaver kidneys in the United States. 
 
 
Criterion  
Points  
Awarded 
Zero antigen mismatch mandatory share
MHC mismatches  
  0 BDR  2 
  1 BDR  1 
  2 BDR  0 
Presensitization  
  Panel reactive antibody ? 80% 4 
Waiting time  
  Longest wait (then fractional) 1 
  Each year on list 1 
Age   
  <11 y  4 
  11-18 y  3 
 
Source:  Young, C.J., Kew C. Health disparities in transplantation: focus on the complexity 
and challenge of renal transplantation in African Americans. Med Clin N Am 2005; 89:1003-
31. 
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approach, prospective evaluation of its merits is pending.  Alternatively, in light of increasing 
recognition of the influence of non-immunologic factors (particularly early graft function and 
donor age) on long-term survival, it may be time to formulate a completely new paradigm for 
organ allocation, especially in light of the success that has been achieved with PKT. 
 
PREEMPTIVE KIDNEY TRANSPLANTATION 
 Transplantation is recognized as preemptive if it takes place before the initiation of 
chronic maintenance dialysis. PKT is an appealing option for patients who are approaching 
end stage renal failure but who have not yet progressed to dialysis.  Theoretical advantages 
include avoiding the inconvenience of frequent hemodialysis sessions or frequent exchanges 
of peritoneal fluid, the significant morbidity associated with multiple access procedures, the 
risk related to repeated blood transfusions, and the complications of prolonged uremia 
(Papalois et al., 2000).  In addition, preemptive transplantation eliminates the substantial cost 
of dialysis. 
 In the past there was some concern that this strategy might be associated with an 
increased risk of graft loss from rejection, because these patients would not experience the 
immunosuppressive effects of uremia.  In addition, it has been suggested that compliance 
after transplantation might be reduced if the patients had not experienced dialysis as the first 
modality of renal replacement therapy.  However, a number of recent reports indicate that 
PKT gives the clear benefits of not only avoidance of morbidity associated with dialysis and 
reduced cost of renal replacement therapy but also significant increases in both patient and 
graft survival (Roake et al., 1996).  PKT decreased the rate of allograft failure by 25% for 
cadaver donor transplants (Kasiske et al., 2002).  The basis for the allograft survival 
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advantage in preemptive recipients is unclear.  Possibilities include a lead time bias due to 
the earlier transplantation of patients with preserved native kidney function, less rapid loss of 
kidney function after transplantation, or the longer patient survival of PKT recipients. 
Despite the success of PKT in reducing the rate of allograft failure, it accounts for only 7% to 
8% of cadaver donor transplants (Kasiske et al., 2002).  
 While it is hypothesized that the lower rate of PKT among cadaver donor transplants 
likely resulted from the prolonged duration of time waiting for a cadaver donor, this 
hypothesis is not supported by the literature.  Previous studies using national data from the 
UNOS transplant registry have associated socioeconomic characteristics with rates of 
placement on the cadaver waiting list (Kasiske et al., 1998) and with the likelihood of 
receiving a cadaver renal transplant before the initiation of dialysis (Kasiske et al., 2002).  
Although these results have been informative, analysis of the UNOS registry does not allow 
for determination of the factors that affect the decision and timing of either PKT or 
placement on the waiting list.  
 Other studies have examined data exclusively from patients already on dialysis and, 
therefore, were not designed to address reasons associated with transplant evaluation before 
dialysis initiation (Alexander & Sehgal, 1998; Ayanian et al., 1999; Winkelmayer et al., 
2002).  The factors that influence the decision to designate patients for PKT or dialysis are 
not well understood. Given the importance of the timing of PKT, the current study was 
performed to understand the factors that contribute to preemptive versus non-preemptive 
transplantation among persons who experienced renal failure and received a cadaver kidney 
transplant during a five year period from 2000 through 2003.  
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PROBLEM STATEMENT 
 Dialysis has long been the established initial choice of therapeutic intervention for 
patients with ESRD.  However, not only is dialysis associated with significant morbidity and 
a greater mortality than transplantation, but it is also expensive.  Because of a clear survival 
benefit associated with renal transplantation, it has now become generally regarded as the 
preferred treatment option for ESRD.  Kidney transplant recipients have been shown to live 
longer, have a higher quality of life, and consume fewer health care resources compared with 
patients on dialysis (Eggers, 1995; Wolfe et al., 1999; Winkelmayer et al., 2002).  Kidney 
transplantation typically takes place after a period of dialysis.  Recently, transplantation 
before initiation of dialysis has been advocated because the morbidity and cost of putting in a 
stint for dialysis access are avoided.  PKT has been associated with an allograft survival 
advantage compared with transplantation after initiation of dialysis (Kasiske et al., 2002).   
 Ethnic disparities in access to renal transplantation are long standing and may be 
increasing (Callender, 1991).  The incidence of ESRD in blacks is 4 times greater than that in 
whites, but blacks remain less likely than whites to be referred for or undergo traditional 
post-dialysis renal transplantation (Young & Gaston, 2002).  Eggers noted that blacks with 
ESRD have limited access to transplantation relative to whites (Eggers, 1988).  Blacks 
receive only 25% of cadaver kidneys and have a median waiting time for a cadaver kidney 
that is twice as long as that of whites (UNOS 1999 Annual Report).  Black ESRD patients, 
once fully informed of their options, prefer transplantation over dialysis as often as whites 
but are significantly less likely to proceed rapidly to transplantation (Young & Gaston, 
2002).  Broad opinion is that blacks are being referred at a lesser rate than whites for 
traditional post-dialysis transplants (Young & Gaston, 2002) and a hypothesis of this 
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research is that they are being referred at a lesser rate for PKT as well.  The observation that 
whites are more likely to be placed on the cadaver waiting list before dialysis initiation and 
receive a PKT suggest that there is some systemic bias in determining who receives and does 
not receive PKT (Kasiske et al., 1998; Kasiske et al., 2002).  The focus of this research was 
to attempt to determine if blacks are being afforded PKT at a rate equal to that of whites and, 
if not, to determine if there are objective variables that may account for the difference, such 
as differences in comorbidities or insurance coverage.  
 
PURPOSE OF THE STUDY 
 The purpose of this research was to determine whether there are inequities in the 
allocation of cadaver kidneys for preemptive kidney transplants (PKT) between blacks and 
whites. 
 
RESEARCH OBJECTIVE 
 The objective of this study was to identify differences between blacks and whites who 
experienced kidney failure and received either standard or preemptive cadaver donor kidney 
transplants during the four year period between 2000 and 2004.  There were three specific 
aims: 
1. Specific aim 1 was to make a comparison by race of the demographic characteristic 
of PKT and conventional transplant recipients.  
2. Specific aim 2 was to make a comparison by race of the health state, post transplant 
outcomes and time relative to transplantation of PKT and conventional transplant 
recipients.  
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3. Specific aim 3 was to determine if a racial disparity exists in the receipt of PKT 
versus conventional cadaver kidney transplants. 
 
DEFINITIONS OF TERMS AND CONCEPTS 
 The following were key terms and concepts used in this study: 
1. chronic kidney disease (CKD):  Term used to describe the whole continuum of 
progressive kidney disease, from chronic renal insufficiency (CRI) through and 
including end stage renal disease (ESRD). 
2. chronic renal insufficiency (CRI):  Condition in which the kidneys gradually lose 
their ability to perform their primary functions, the removal of wastes and extra fluid 
from the body. 
3. dialysis:  Artificial process of cleaning wastes from the blood when kidneys fail. The 
two major forms of dialysis are hemodialysis and peritoneal dialysis. 
4. end stage renal disease (ESRD):  Total kidney failure that requires dialysis to 
remove wastes and fluids from the bloodstream or kidney transplantation.  For 
purposes of this investigation, ESRD occurs on the date of first service for dialysis. 
5. hemodialysis:  Use of a machine to clean wastes from the blood after the kidneys 
have failed. The blood travels through tubes to a dialyzer, which removes wastes and 
extra fluid. The cleaned blood then flows through another set of tubes back into the 
body. Hemodialysis is usually performed at a hospital, dialysis clinic, or doctor's 
office. 
6. peritoneal dialysis:  Process by which the blood is cleansed using the lining of the 
abdomen as a filter. A cleansing solution, called dialysate, is drained from a bag into 
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the abdomen. Fluids and wastes flow through the lining of the abdomen and remain 
"trapped" in the dialysate. The dialysate is then drained from the abdomen, removing 
the extra fluids and wastes from the body. Typically, peritoneal dialysis can be 
performed by the patient at home. 
7. pre-emptive kidney transplant (PKT):  Process recognized as preemptive if it takes 
place before the initiation of chronic dialysis. For the purposes of this investigation 
any transplantation which occurred within six months of the date of first service for 
dialysis is preemptive. 
 
ASSUMPTIONS 
 The following assumptions were made regarding this research: 
  
1. The data in the ESRD Program Management and Medical Information System and 
the Renal Beneficiary and Utilization System (PMMIS/REBUS) database is reflective 
of the actual status of the population that these data represent. 
2. The statistical analysis is reliable and valid. 
3. Patients were placed on dialysis because of signs, symptoms, and laboratory 
indicators of ESRD, and not for other, non-medical reasons. 
 
LIMITATIONS OF THE STUDY 
 The limitations of this research included the following: 
1. The PMMIS/REBUS database is dynamic, and the results reported in the 
investigation therefore represent only a cross section of time. 
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2. There is limited information on what is occurring in the individual market where 
patients receive care. 
 
ORGANIZATION OF THE STUDY 
 This dissertation is organized into five chapters.  In Chapter 1 the background of 
disparities in kidney transplantation and issues related to PKT are discussed.  The purpose of 
the study is to explore the inequities of standard and PKT.  Chapter 2 provides a review of 
the literature, which includes an analysis of research specifically focused on the differences 
between blacks’ and whites’ access to kidney transplantation.  The literature review also 
includes a review of factors that affect the selection process for PKT.    Chapter 3 describes 
the methods used in conducting the analysis, and Chapter 4 presents the results of these 
analyses.  Chapter 5 concludes with a discussion of the findings and possible next steps 
advanced by this work.  
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CHAPTER 2.  REVIEW OF THE LITERATURE 
 
RACIAL DIFFERENCES IN ACCESS TO KIDNEY TRANSPLANTATION 
 Racial differences in access to conventional or PKT involve several elements.  
Included among the most influential of these are when blacks are diagnosed with chronic 
kidney disease, when they are referred to a specialist, and when they are placed on the 
transplant waiting list.  Each of these junctures in the transplant process reflects racial 
differences in access to transplantation, which will be reviewed.  
 Eggers (1995)
 
went beyond previous works that had examined differences between 
black and white transplant populations.  Instead of merely examining overall kidney 
transplant rates and waiting times to measure access to transplantation, he used three 
measures: time from renal failure to transplant, time from renal failure to waiting listing, and 
time from waiting list to transplantation.   
 Three data sets were matched for Eggers’ analysis: (1) The Organ Procurement 
Transplant Network (OPTN) wait list and Health Care Financing Administration (HCFA) 
data sets and (2) the ESRD Program Management and Medical Information System 
(PMMIS).  The OPTN wait list data consists of two files, the current active wait list file and 
the removals file that contains information on persons no longer on the active list.  The wait 
list file used in this study contained 26,025 active records and the removals file 76,417 
records.  The HCFA ESRD PMMIS is a longitudinal file of ESRD patients entitled to 
Medicare benefits that is maintained by HCFA’s Bureau of Data Management and Strategy.  
The ESRD PMMIS file used in this study was updated through April 1994.  This updated file 
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contained 582,330 people, the complete count of Medicare ESRD patients ever entitled since 
1978. 
 Three measures of access to transplantation were derived for this analysis by Eggers 
(1995).  In all three cases, a time-to-event model was used with measure specific censoring.  
There were a total of 79,527 persons under 55 years of age who initiated renal replacement 
therapy during the years covered by the study.  Blacks were most likely to have their renal 
failure attributed to hypertension (34.1%), and males comprised the majority of persons in all 
racial groups, ranging from 52.8% for Asians to 59.8% for blacks.  There was little 
difference in the age distribution.  Incidence overall was 81 per million population.  
Incidence was comparable between Asians and whites; however, compared with whites, 
blacks were almost four times as likely to suffer renal failure.  Access to transplantation was 
inversely related to age, decreasing from 45.7% for persons less than 15 years of age to 8.1% 
for persons 45-54 years of age.  At one year following renal failure, whites were almost four 
times more likely to have received a transplant than blacks.  At five years post renal failure, 
fewer than one-third of blacks (30.3%) had received a transplant, while well over one-half 
(56.7%) of whites had received a transplant.   
 Black ESRD patients were least likely to get wait listed of all racial groups, with only 
17.8% wait listed in the first year of renal failure.  Transplantation rates after wait listing 
were highest for whites; over one-half were transplanted within one year of wait listing.  
However, the ethnic differences narrowed in subsequent years.  For example, the black rate 
was only 68% as great as the white rate in the first year of wait listing.  For those persons still 
not transplanted by the end of the second year, the transplantation rate for black patients was 
90% as great as that for white patients. 
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 Race had a significant impact on all three measures of transplant access. Blacks were 
only 37% as likely as whites to get a transplant (including living donor).  They were only 
64% as likely as whites to get on the wait list and only 66% as likely to get a cadaver 
transplant after being wait listed.  The author concluded that black ESRD patients lagged 
behind white patients in transplantation after wait list enrollment.  A similar disparity existed 
in the primary step of getting on the wait list in the first place.  The investigator concluded 
that no matter what measure of transplant access was used; blacks with ESRD fare worse 
than whites (Eggers, 1995).   In addition, wait times following OPTN enrollment increased 
more for black patients than for any other racial group between 1988 and 1991. 
 Young and Gaston (2000) examined the influence of race on renal transplantation and 
summarized the effect of multiple interrelated scientific and political factors on the care of 
blacks with kidney failure.  The major significance of this work was the authors’ descriptive 
examination of the current United Network for Organ Sharing (UNOS) algorithm for organ 
allocation, which they proposed perpetuates racial disparity (Young & Gaston, 2000).  
Specifically, the authors cited the allocation policy that requires ABO blood type as 
disadvantaging black candidates. This conclusion was attributed to the longer wait times for 
transplantation that were associated with ABO types that occurred more frequently in the 
black population (UNOS 1998 Annual Report).   The longer wait time is a product of the 
relative weight of HLA antigen matching allocated by the UNOS allocation algorithms 
(Young & Gaston, 2000).  This algorithm awards points to wait listed transplant candidates 
based on several factors, including HLA match.  When a kidney becomes available, the 
candidate with the most points is designated to receive that organ.  Because an underlying 
assumption is that similarity in HLA antigen matching between donor and recipient 
  24 
 
optimizes outcomes, matching is the predominant variable determining the allocation of 
cadaver kidneys (Norman et al., 1995).  Therefore the degree of donor recipient match is 
heavily weighted in the algorithm. Thus several immunologic factors combined to place 
blacks at a disadvantage in regard to the HLA match—with the net result being a preference 
for white candidates for transplantation (Young & Gaston, 2000).  Beatty, Mori, and Milford 
(1995) supported this observation, noting that blacks were only 28% as likely as whites to 
find a completely HLA matched donor among 500,000 potential donors.  Young and Gaston 
(2000) pointed out that on the wait list containing more than 60% blacks, only 1 of 33 fully 
matched cadaver kidneys went to a black recipient. They went on to note that, nationally, 
14% of all cadaver kidneys were transplanted into fully matched recipients, of whom 90% 
were white and only 9% were black.  Young and Gaston (2000) concluded that the primary 
benefit of the current allocation system is directed toward the predominantly white recipients 
with completely matched grafts. 
 In another examination of racial disparities in access to renal transplantation, Epstein 
et al. (2000) focused on whether the declining rate of transplantation in blacks was clinically 
appropriate or due to care underuse by blacks or overuse by whites.  Specifically, the critical
 
questions asked were whether blacks were less likely than whites to
 
undergo necessary 
surgical procedures, and whether whites were
 
more likely than blacks to undergo surgical 
procedures when
 
non-surgical management was indicated.
  
 This unique analysis was conducted by using a literature review and an expert panel 
to develop criteria for determining the appropriateness of renal transplantation for patients 
with ESRD.  The criteria were based on the appropriateness of the presence or absence of 
factors constituting absolute or relative contraindications to transplantation.  To develop the 
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criteria, they used the study conducted by RAND (Park et al., 1986) and described by the 
Institute of Medicine (IOM Committee on Clinical Practice Guidelines, 1992).   
 Data on patients with ESRD were obtained from four regional ESRD networks that 
serve geographically diverse areas of Alabama; southern California; Michigan; and the 
District of Columbia, Maryland, and Virginia.  To obtain a sample of 1,500 patients, the 
researchers selected a stratified random sample of blacks and whites from each region.  They 
compared the demographic and clinical characteristics of patients in an analysis stratified 
according to sex as well as race.  The t-test was used for continuous variables and the chi-
square test for categorical variables.  They used two logistic-regression models and a 
multivariate logistic-regression model to examine the effect of covariates on appropriateness 
ratings.  
 The results indicated that blacks were less likely than whites
 
to be rated as appropriate 
candidates for transplantation according
 
to appropriateness criteria (71 blacks
 
[9.0%] vs. 152 
whites [20.9%]). Additionally, blacks were found to be more likely
 
to have had incomplete 
evaluations (368 [46.5%] vs. 282
 
[38.8%], p < 0.001 for the overall chi-square). Among
 
patients considered to be appropriate candidates for transplantation,
 
blacks were less likely 
than whites to be referred for evaluation,
 
(90.1% vs. 98.0%, p = 0.008), to be placed on a 
waiting list (71.0% vs. 86.7%, p = 0.007), or to undergo transplantation (16.9 % vs. 52.0%,   
p < 0.001). Among patients classified as
 
inappropriate candidates, whites were more likely 
than blacks
 
to be referred for evaluation (57.8% vs. 38.4%),
 
to be placed on a waiting list 
(30.9% vs. 17.4%),
 
and to undergo transplantation (10.3% vs. 2.2%, p < 0.001 for all three 
comparisons).
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 Epstein et al. (2000) concluded that racial disparities in rates of renal transplantation
 
stemmed from differences in clinical characteristics that affected
 
appropriateness as well as 
from underuse of transplantation
 
among blacks and overuse among whites. In the opinion of 
the authors, reducing racial disparities
 
would require efforts to distinguish their specific 
causes and
 
the development of interventions tailored to address them.   
 The conclusions reached by Epstein et al. (2000) support the earlier conclusions 
reached by Alexander and Sehgal (1998), who
 
documented a sequence of potential barriers 
along the clinical
 
pathway to renal transplantation. It was the position of the researchers that 
intervention at any single
 
point is unlikely to eliminate racial disparities. Their findings
 
that 
blacks were less likely to be appropriate candidates for
 
transplantation than were whites 
suggest that even if blacks
 
and whites had equal access to renal transplantation, their
 
rates of 
referral, placement on a waiting list, rate of transplantation
 
or their cost break-even point 
might not be the same. 
 Epstein et al. (2000) readily acknowledged several limitations of their study. First, the 
number of patients in the underuse group considered to be appropriate
 
candidates for 
transplantation was small, possibly allowing unstudied factors to bias the results.  Second, 
appropriateness
 
ratings varied among expert panels, and the number
 
of persons in overuse 
and underuse categories would, therefore, likely
 
vary according to the particular panel used. 
However, the researchers propose that this variation would
 
not affect racial differences in
 
ratings. Third, the study sample was restricted to persons
 
between the ages of 18 and 54 
years. Whereas a substantial proportion
 
of patients receiving dialysis for the first time were 
55 or
 
older, there was also a substantial decline in rates of transplantation
 
among older 
patients.  Finally, the study examined a condition for
 
which almost all patients in the United 
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States have insurance
 
coverage through Medicare and are in close contact with the medical 
care system through dialysis and transplantation two factors that would be expected to reduce 
racial
 
disparities in care.
  
 
Foster et al. (2002) reviewed renal transplantation in blacks over a ten year period.  
Their objective was to evaluate the strategies instituted by a transplant center to decrease 
time on the waiting list and increase the rate of transplantation for blacks.  The intervention 
consisted of a formal education program oriented toward blacks concerning benefits of living 
organ donation.  
 During the study period, from March 1990 to November 2001, data were obtained 
from 2,167 renal transplants; 944 were blacks (663 primary cadaver renal transplants and 253 
primary living donor renal transplants).  Outcome measures of this historical cohort study 
found median waiting time for cadaver renal transplant for whites was 391 days compared 
with 647 days for blacks.  Foster et al. (2002) concluded that programs specifically oriented 
to improving volunteerism in blacks lead to a marked improvement in overall waiting time 
and in rates of living donation in the patient group.  The median waiting times for cadaver 
renal transplantation were also significantly shorter.  These programs markedly improved 
ESRD care for blacks by cutting in half the overall waiting time while still achieving 
comparable graft and patient survival rates.  It should be noted that the results of this study 
were only qualitative, non-statistical comparisons that used a methodology for calculating 
waiting time that was different than that used by UNOS, which takes into account death on 
the waiting list.  Additionally, some transplant programs do not register living donors with 
UNOS, possibly inflating overall waiting time. 
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 A racial difference in access to the kidney transplant waiting list has also been found 
in pediatric patients.  Furth et al. (2000) sought to determine whether the increased time to 
transplantation for black pediatric patients was attributable not only to a shortage of suitable 
pediatric donor organs but also to racial differences.  They conducted a national longitudinal 
cohort study of U.S.-Medicare-eligible pediatric ESRD patients.  Study subjects included 
children and adolescents < 19 years old at the time of their first dialysis between 1988 and 
1993, who were followed though 1996.  Patients who received living donor renal transplants 
were excluded from the study.  The primary outcome measures were the time from first 
dialysis until activation on the kidney transplant waiting list and the likelihood of activation 
on the waiting list for black compared with white pediatric patients. 
 Furth et al. (2000) found that for the 2,162 white (60.7%) and 1,122 black (31.5%) 
patients studied using survival analysis, blacks were less likely to be wait listed at any given 
time in follow up.  In multivariable
 
analysis even after controlling for patient age, gender, 
socioeconomic
 
status, geographic region, incident year of renal failure, and
 
cause of ESRD 
blacks were 12% less likely to be wait listed than
 
whites at any point in time (relative hazard: 
0.88; 95% confidence
 
interval; 0.79-0.97).  
 Among black patients, 28.6 patients were
 
wait listed per 100 person-years of follow 
up, compared with 33.9
 
for whites. Two hundred fifty-two patients (7.7%) were activated on
 
the waiting list before their first dialysis; 76% of these patients
 
were white. The cumulative 
incidence of patient wait listing according
 
to race is shown in Fig. 2-1. Kaplan-Meier 
analyses demonstrated
 
that at any point in time black patients were less likely than
 
were 
white patients to be activated on the kidney transplant waiting
 
list (P = .007, log-rank test).  
The disparity was present early on
 
and remained relatively constant over time. 
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Figure 2-1. Cumulative incidence of wait listing for black and white pediatric patients 
after first dialysis for ESRD. 
 
Source:  Furth S.L., et al. Racial differences in access to the Kidney Transplant Waiting List 
for Children and Adolescents with ESRD. Transplantation, 2000; S237.  Reprinted with 
permission. 
 
 
 
 To assess the independent effect of race on time from first dialysis until activation on 
the kidney transplant waiting list, Fruth et al. (2000) performed a Cox proportional hazards 
analysis and found that even after controlling for important confounders identified in the 
Kaplan-Meier analyses (including patient age, gender, socioeconomic status, assigned cause 
of ESRD, geographic region, and incident year of dialysis), blacks were still 12% less likely 
than whites to be activated on the kidney transplant waiting list (relative hazard: 0.88; 95% 
confidence interval [CI]: 0.79, 0.97). 
 Several limitations of the Fruth et al. (2000) study deserve mention. Any errors in the 
recorded dates of first dialysis and first wait listing
 
would be expected to be random and not 
associated with patient
 
race. This random misclassification would tend to minimize rather
 
than exaggerate the racial differences in time from first dialysis
 
for ESRD to activation on the 
wait list that the researchers saw. 
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 Fruth et al. (2002) concluded that racial disparities in access to the renal transplant 
waiting list existed when black children experienced delayed access to this therapy. 
Whether these disparities were attributable
 
to differences in time of presentation to 
nephrologists, physician
 
bias in identification of transplant candidates, or patient preferences
 
warrant further study.  This is the first known report that documents the racial differences in 
access to renal transplantation extended beyond the adult population to include children.   
 Young and Gaston (2002) reviewed published reports that examined the connection 
between race and the incidence of chronic renal failure, access to optimal therapy, and 
outcomes of renal transplantation.  This research underscored the point that blacks with 
ESRD are at the epicenter of continued debate about access to transplantation of renal 
allograft.  The literature reviewed in this area pointed out that the impact of race on delivery 
of care in ESRD remains controversial.  According to the authors, it was the exaggerated 
incidence of kidney failure among blacks, along with the under-representation of those 
patients receiving cadaver renal allograft that continues to fuel the controversy.  Young and 
Gaston’s brief review was intended to summarize the impact of multiple interrelated 
scientific and political variables on blacks with kidney failure.  Summarizing Young and 
Gaston’s 2002 review, the incidence of ESRD in blacks was four times greater than that in 
whites, but blacks remained less likely than whites to be referred for or to undergo renal 
transplantation. Blacks remained disadvantaged in both access and outcomes.  The authors 
concluded that further evaluation of underlying causes and development of specific remedies 
are warranted. 
 Ayanian et al. (2004) conducted research on physicians’ beliefs about racial 
differences in referral for renal transplantation. According to Ayanian et al. (2004) a better 
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understanding of physicians’ views about racial differences in access to transplantation might 
help reduce disparities in care. Their study surveyed 278 nephrologists in four U.S. regions 
regarding quality of life and survival for blacks and whites undergoing renal transplantation 
and also the reasons for racial differences in access to transplantation. They also surveyed 
606 of their own patients about their care.  The physicians were less likely to believe that 
transplantation improved survival for blacks than whites (69% versus 81%; P = 0.001), but 
were likely to believe it improved quality of life (84% versus 86%). Factors commonly cited 
by physicians as important reasons why blacks are less likely than whites to be evaluated for 
transplantation included patients’ preferences (66%), availability of living donors (66%), 
failure to complete evaluations (53%), and comorbid illnesses (52%). Fewer physicians 
perceived patient-physician communication and trust (38%) or physician bias (12%) as 
important reasons. Black patients were less likely than white patients to report receiving 
some or a lot of information about transplantation (55% versus 74%; P = 0.006) when their 
physicians did not view patient-physician communication and trust as an important reason for 
racial differences in care.  Aryanian et al. (2004) concluded that nephrologist’ views about 
the benefits of renal transplantation and reasons for racial differences in access might have 
affected how they present this treatment option to black and white patients. 
 
PREEMPTIVE KIDNEY TRANSPLANTATION 
 Until the mid-1980s, the general feeling was that PKT was associated with inferior 
results compared with post dialysis transplantation (Jacobs et al., 1977) but the literature 
remained sparse.  However, the later published clinical experiences of PKT in adults 
(Migliori et al., 1987; Tegzess et al. 1987; Katz et al., 1991) suggested that the outcome 
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might not be different from that following conventional cadaver transplantation.  Migliori et 
al. (1987) reported a case control study of 132 preemptive transplants performed between 
1968 and 1984.  Those from cadaver donors (36 transplants) had relatively poor outcomes, a 
finding which was attributed to the high number of diabetics in this group.  Katz et al. (1991) 
reported 85 consecutive preemptive transplants (47 and 38 from living and cadaver donors, 
respectively) between 1981 and 1988.  Patient and graft survival rates were not different 
from those of the controls for the group as a whole or for living and cadaver donors analyzed 
separately.  However, according to this investigation the preemptively transplanted group 
experienced significantly more rejection episodes attributed to noncompliance.  
 With the work of Tegzess (1987), Migliori (1987), and Katz (1991) leaving questions 
about PKT unanswered, Roake et al. (1996) conducted an analysis to compare the results of 
conventional cadaver renal transplantation with PKT at the Oxford Transplant Center.  They 
sought to establish whether or not PKT could be justified on the basis of clinical outcome.  
For the purposes of their analysis Roake et al. (1996) defined PKT as the first transplantation 
before the need for chronic dialysis, including patients in whom the first dialysis was no 
more than 48 hours before transplantation.  The analysis was a retrospective case-control 
study, subject to the risk of bias inherent in this type of analysis.  The controls were selected, 
as far as possible, to be well matched to the PKT group, but some significant differences 
were present with respect to several variables that could have potential impact on graft 
survival.  Furthermore, as a direct result of the study design, the controls developed ESRD 
failure at an earlier age than the PKT group, possibly as a consequence of more aggressive 
primary disease and this difference may have influenced patient survival. 
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 Patients who underwent PKT between June 1976 and December 1994 at the Oxford 
Transplant Center were compared with matched controls of first cadaver transplant recipients 
who were dialysis dependent when transplanted.  The 116 patients in the PKT cohort were 
well matched to the control group with respect to sex, and blood group, and HLA match, 
degree of sensitization, donor age, immunosuppression, and year of transplantation.  Both 
patient and graft survival were significantly better in the PKT group   Differences in graft 
survival did not appear to be explained completely by better patient survival.  Among 
surviving grafts there were no significant differences in graft function, as assessed by 1, 2, 
and 3 year plasma creatinine levels.  Roake et al. (1996) concluded that PKT appeared to be 
safe and might even be associated with superior graft survival when compared with 
conventional transplantation.  In a cautionary admonishment, they stated that early inclusion 
on a transplant waiting list with a view to PKT could be justified with respect to the clinical 
outcomes, but the financial costs and implications for the utilization of cadaver donor 
kidneys must also be considered.    
 By 2000, the research on PKT had shifted to an argument against waiting until 
dialysis.  Papalois et al. (2000) acknowledged that PKT had not been favored in some centers 
because of concern about possible increased noncompliance and allegedly inferior long term 
results and analyzed their experiences to determine whether such concerns were justified.  
This research was an extension of previously reported research (Migliori et al., 1987) that 
found no significant disadvantages with PKT.  In the follow up study the purpose of the 
analysis was to assess the potential benefits of PKT for long term patient and graft survival 
rates as well as for post transplantation quality of life.  Papalois et al. (2000) reviewed their 
centers’ experience with 1,849 primary adult kidney transplants from January 1, 1984 to June 
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30, 1998.  The analysis included 385 PKT and 1,464 non- PKT.  The results were subdivided 
by donor source: cadaver and living donor.  The PKT patients tended to be younger, but 
otherwise the two groups were similar. 
 The 5-year actuarial patient survival rate was superior for PKT patients regardless of 
donor source (96.6% vs. 76.6%, p = 0.001 for cadaver transplants and 93.3% vs. 89.5%, p = 
0.02 for living donor transplants).  The results were significantly higher for PKT recipients 
compared with recipients undergoing dialysis for < 1, 1-2, and > 2 years pre-transplant for 
both cadaver and living donor transplants.  The conclusions reached were that PKT patients 
did not seem to have higher rates of noncompliance than those receiving dialysis.  The results 
also seemed to indicate superior outcomes for PKT patients than for those who underwent 
some period of dialysis, supporting the contention that renal failure patients should, if 
possible, undergo transplantation before chronic dialysis.  The quality of life for the PKT 
patients and those who received dialysis did not differ, nor did the post transplantation 
employment status.  The results clearly refuted the argument that PKT decreased the quality 
of life or disabled PKT recipients.  The superior outcome associated with PKT raised the 
issue of optimal timing for transplantation. 
 Beginning where Papalois et al. (2000) left off, Kasiske et al. (2002) further examined 
whether PKT actually was beneficial and, if so, who benefited.  Using UNOS and USRDS 
data, they examined the characteristics of patients who received PKT.  They also examined 
whether the effects on outcomes were similar in both cadaver and living donor transplant 
recipients, and whether these effects were independent of recipient age, year of 
transplantation, and other factors.  The analysis retrospectively examined 38,836 first kidney-
only transplants between 1995 and 1998.  Surprisingly, 39% of the PKT were from cadaver 
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donors; however, it should be noted that the proportions of cadaver donor transplants that 
were PKT changed very little—from 7.3% in 1995 to 7.7% in 1998.   
 In the study of Kasiske et al. (2002), the researchers found that there was a greater 
likelihood of PKT among patients who (1) had a living donor; (2) were younger than 18 
years old; (3) were white; (4) were not Hispanic; (5) were better educated; (6) were working 
full time; (7) had a primary payer other than Medicare; and (8) had 0 to 1 HLA-antigen 
mismatches.  PKT was relatively more likely among children in this study, given that every 
effort is made to transplant children as soon as possible to improve their growth and 
development.  Patients who received PKT were more likely to be employed both before and 
after transplantation than patients who did not receive PKT.  Race and education were each 
independently associated with preemptive transplantation. One of the strongest correlates to 
preemptive transplantation was the primary source of payment.  Patients who had Medicare 
as the primary payer were much less likely to receive preemptive transplantation.  As the 
researchers pointed out, having Medicare as the primary payer could have been a surrogate 
for other factors, such as ethnicity. They concluded that the need to rely on Medicare itself 
may have discouraged PKT. 
 In conclusion, the results of this study (Kasiske et al. 2002) strongly suggested that 
PKT is beneficial.  The reason for this additional, long term benefit associated with PKT 
remained unclear, but the researchers hypotheses that it could be related to the avoidance of 
one or more comorbidities, e.g., cardiovascular disease, that may have otherwise developed 
during treatment with maintenance dialysis.   
 PKT is associated with allograft survival advantage and is promoted in part because 
of this association.  Because the basis for the allograft survival advantage in preemptive 
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recipients remains unclear, Gill et al. (2004) further explored this relationship by focusing on 
the possibility that the advantages seen in PKT patients were due to a lead time bias derived 
from the earlier transplantation of patients with preserved native kidney function. Other 
possibilities included less rapid loss of kidney function after transplantation, or the possibility 
that the advantage could be explained simply by longer patient survival of PKT patients.  
 In attempting to determine why PKT recipients had an allograft survival advantage, 
Gill et al.(2004) research focused their research on a comparison of the glomerular filtration 
rate (GFR) six months after transplantation and the subsequent rate of loss of kidney function 
as defined by the annualized change in GFR (mL/min/1.73
2
/year) in 5,966 preemptive and 
34,997 non-preemptive recipients.  Linear regression methods were applied to serial GFR 
estimates after transplantation to determine the annualized change in GFR.  Multiple 
regression was used to determine the independent effect of preemptive transplantation upon 
the annualized change in GFR.   The results showed that the mean GFR 6 months after 
transplantation was similar among PKT (49.5 ± 15.7 mL/min/1.73m
2
) and non-preemptive 
(49.2 ± 14.7 mL/min/1.73m
2
) recipients (P = 0.37).  In multivariate analysis, preemptive 
recipients had a slower decline in GFR (0.28 mL/min/year/1.73m
2
; 95% confidence interval 
0.11, 0.46; P = 0.002).  However, this difference was of modest clinical significance and 
would not explain the allograft survival advantage of preemptive transplantation.  Having 
found no meaningful significance, the researchers concluded that neither the preservation of 
native kidney function nor differences in the rate of loss of kidney function explained the 
superior allograft survival of preemptive recipients.  They concluded with the hypothesis that 
the apparent allograft survival advantage of PKT is the result of improved patient survival   
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resulting from patient selection or the reduced severity of comorbid disease associated with 
avoidance of dialysis. 
 The Gill et al. (2004) analysis found that PKT was more common among non-blacks.  
Other reports in the literature also indicate that whites are more likely than blacks to have a 
living donor.  In addition, PKT recipients were found to be younger, female, and non-HLA 
mismatched patients, and patients with polycystic disease.  
 Kasiske et al. (1998) conducted an analysis specifically focused on race and 
socioeconomic factors influencing early placement on the kidney transplant waiting list.   
This cohort study investigated whether there were inequities in the current system for listing 
patients for cadaver renal transplantation, using bivariate and multivariable analyses to 
identify factors associated with early registration before initiation of dialysis.  While this 
analysis did not focus on PKT specifically, the examination of waiting times is relevant in 
creating a perspective for other literature to be reviewed and the analysis conducted in the 
current research that looked at the differences in PKT rates between blacks and whites. 
 Kasiske et al. (1998) noted that UNOS has established a system for allocating kidneys 
for cadaver transplantation that is designed to be both equitable and efficient.  The UNOS 
point system for allocating kidneys awards points for waiting time, so that individuals who 
have waited longer are more likely to receive a kidney, all other factors being equal (UNOS 
Policy 3.5: Allocation of Cadaver Kidneys, 1997).  Based on this policy, it is clear that 
physicians and patients want registration to take place as soon as possible, to begin accruing 
waiting time.  It is certainly an advantage to register for transplantation before initiating 
maintenance dialysis.  According to the authors, registering before dialysis theoretically may 
allow patients to receive a transplant before initiating dialysis, and thereby obviating the need 
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for permanent dialysis access.  However, given the long waiting time, PKT is usually not 
possible with a cadaver kidney.  Although the research perspective articulated by Kasiske et 
al. (1998) was that registering before transplantation usually offers no practical advantage 
other than waiting time accrual, Kasiske et al. (1998) used registration before maintenance 
dialysis initiation as an indicator of early listing for cadaver renal transplantation.  Because 
listing before dialysis may be advantageous with regard to waiting time accrual, the 
investigators sought to determine whether there were differences in patients who did or did 
not register before dialysis.  Major differences in patients who registered before versus those 
who registered after initiating dialysis could indicate potential inequities in the allocation 
system, and/or in access to health care in general. 
 The analysis of Kasiske et al. (1998) included all patients who registered with UNOS 
on the OPTN kidney and kidney pancreas waiting list between April 1, 1994, and June 30, 
1996 (n = 41,596) from all 238 UNOS renal transplant centers.  The information in the 
database was collected using the UNOS Transplant Candidate Registration Form.  The 
research included the following variables: gender, age, history of previous kidney transplant, 
highest education level achieved, ethnicity, employment status, projected payment source, 
registration at a high volume center, diabetes/insulin dependent, kidney versus kidney 
pancreas registration, functional status at registration, and the year of listing (1994, 1995, 
1996).  The statistical analysis included both bivariate and multivariable analyses (Kasiske et 
al., 1998). 
 In the univariate analysis, of all the registrations—41,596 (18.4%)—were not yet on 
dialysis.  A number of characteristics were different between those not yet on dialysis and 
those on dialysis at the time of listing.  Although 59.3% of all registrations were male, of 
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those not yet on dialysis, only 57.7% were male.   Those not yet on dialysis were younger 
and more likely to have had a prior transplant.  They were better educated and were more 
often white.  They were more likely to have private insurance, listed at a high volume center, 
to be diabetic.  The multivariable analysis revealed that for all registrations, the odds of being 
listed before undergoing maintenance dialysis were 15% greater for females compared with 
males.  Individuals with a prior transplant were 80% more likely to be listed before dialysis.  
The more years of schooling a patient had, the more likely the patient was to have been listed 
before dialysis.  Blacks were 47% as likely as whites to be listed before dialysis.  Individuals 
employed full time were more likely to be listed before dialysis compared with those who 
were working less than full time.  Compared with patients with other payment sources, those 
whose primary source of payment was Medicare were only 34% as likely, whereas those 
with private insurance were 21% more likely to be listed before dialysis.  Of special note was 
that 0 to 8 years of education correlated with a greater likelihood of being listed before 
dialysis, compared with a reduced likelihood when the larger population of patients was 
analyzed. 
 Kasiske et al. (1998) assumed that pre-dialysis at the time of listing could be used as 
an indicator of placement on the waiting list earlier in the course of renal disease than 
registration of patients who were already on dialysis.  They also assumed that patients were 
placed on dialysis because of signs, symptoms, and laboratory indicators of ESRD, and not 
for other, non-medical reasons.  They concluded that it is advantageous for patients to be 
placed on the waiting list as soon as possible, because waiting time adds points to the total 
UNOS point score and thereby helps determine how long a patient may wait for a kidney.  
The greater the number of points the more likely the patient will be transplanted soon.  
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Listing patients as soon as possible is also advantageous to centers that may wish to 
transplant as may patients as soon as possible.  As a matter of fact in the Kasiske et al. (1998) 
study, a logistic regression model testing for center effect did indeed find that some centers 
listed patients sooner (before dialysis) more often than other centers.   
 Kasiske et al. (1998) found that race and socioeconomic factors influenced early 
listing.  Patients who were younger, better educated, white, and working full time, and who 
had better insurance coverage were more often listed before dialysis (compared with patients 
who were older, less well educated, or a racial or ethnic minority working less than full time, 
and who had less insurance coverage).  Kasiske et al. (1998) concluded that early listing can 
now be added to a growing number of steps along the road to renal transplantation that seem 
to be influenced by ethnicity, gender, and socioeconomic factors.  Identification of potential 
candidates for renal transplantation is influenced by ethnicity, gender, employment status, 
and education level (Soucie et al., 1992).  Furthermore research of Soucie et al. (1992) 
supports the proposition that even after having been placed on the cadaver transplant wait list 
the, ethnicity, age, and gender of transplant candidates have been shown to affect the waiting 
time. 
 Several recent studies reflected in this literature review have confirmed the survival 
advantage for renal transplant patients over those waiting on a transplant receiving 
maintenance dialysis.  Meier-Kriesche et al. (2000) furthered this work by investigating the 
hypothesis that longer waiting times are more deleterious than shorter waiting times, that is, 
their objective was to detect a “dose effect” for waiting time.  The issue of waiting times is 
addressed herein due to the direct impact this factor has on the decision for PKT. 
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 Meier-Kriesche et al. (2000) included 73,103 primary adult renal transplants 
registered at the USRDS registry from 1988 to 1997 with the primary end points of death 
with functioning graft and death censored graft failure.  All Cox proportional hazard models 
were corrected for donor and recipient demographics and other factors known to affect 
outcome after kidney transplantation.  The study sample consisted of patients who underwent 
solitary primary (multiorgan and secondary transplants were excluded from the analysis) 
renal transplantation.  Waiting time on dialysis was calculated from the start of maintenance 
dialysis treatment to transplant date.  The impact of waiting time on dialysis prior to 
transplantation on the primary end points was analyzed both as a continuous variable and as a 
categorical variable. The results showed increasing waiting time on dialysis was a significant 
risk factor for death-censored graft loss after renal transplantation (P < 0.001).  Being on 
dialysis for up to 6 months prior to transplantation conferred a 17% increased risk for death-
censored graft loss as compared with PKT when adjusted for all factors considered in this 
analysis.  Dialysis treatment for 6 to 12, 12 to 24, and 24 to 36 months prior to renal 
transplantation conferred a 37%, 55%, and 68% higher risk for death-censored graft loss, 
respectively.  Beyond 36 months of dialysis, there remained a significantly increased risk of 
death censored graft loss as opposed to PKT (P < 0.001); however the relative increase 
beyond 36 months from 68% to 70% to 74% was small and not statistically significant.  
Other significant risk factors for death-censored graft loss were black recipient (P < 0.001), 
black donor (P < 0.001), higher donor age (P < 0.001), higher HLA mismatch (P < 0.001) 
and diabetes as the cause of ESRD (P < 0.001).  When adjusting for all factors being 
considered in this analysis increasing waiting time on dialysis was also a significant risk 
factor for patient death with a functioning graft after renal transplantation (P < 0.001). 
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 Meier-Kriesche et al. (2000) demonstrated that waiting time on dialysis is a strong, 
independent risk factor for decreased patient survival as well as decreased death-censored 
graft survival following renal transplantation.  This effect was independent of all other 
factors in the model (including recipient age, ethnicity, original disease, and donor 
characteristics) and likely reflects a true negative effect of waiting time on dialysis.  This 
effect appeared to be “dose dependent” the longer the waiting period the greater the risk for 
either of these negative outcomes.  Meier-Kriesche et al.(2000) provided strong support for 
the hypothesis that patients who reach ESRD should receive a renal transplant as early as 
possible in order to enhance their chances of long term survival. 
 Failure to complete the medical evaluation for renal transplantation may impede 
access to transplantation and preclude the possibility of PKT.  Research conducted by Weng 
et al. (2003) sought to (1) characterize completion rates of the transplantation medical 
evaluation and (2) determine factors associated with completion of the evaluation.  The 
research was conducted based on the hypothesis that patients not yet on dialysis therapy 
complete the evaluation process more quickly than patients receiving dialysis.  Between 
September 2002 and September 2003, patients evaluated for renal transplantation at the 
Hospital of the University of Pennsylvania (Philadelphia, PA) were enrolled in an 
observational, prospective, cohort study.  Of 356 patients who presented for evaluation, 175 
patients were included in this analysis. The electronic medical record (EMR) was examined 
after all patients had the opportunity to accrue a minimum of 6 months of follow-up since 
their initial evaluation.  The transplantation evaluation was considered complete if the patient 
was placed on the UNOS waiting list for a deceased donor renal transplant or the patient 
received a renal transplant, whichever occurred first.  As standard practice for this transplant 
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center, all patients who successfully completed the medical evaluation were listed for a 
deceased donor renal transplant.  Therefore, the transplant center staff considered the listing 
for deceased donor transplantation to signify successful completion of the pre-transplantation 
workup.   
 Weng et al. (2003) examined the association between dialysis status at the initial 
transplantation evaluation visit and time until completion of the medical evaluation.  A Cox 
proportional hazard model was fit to examine the relationship between baseline covariates, 
particularly dialysis status, and time to completion of the transplantation evaluation.  Of the 
175 study participants, a slight majority (54.3%) were receiving maintenance dialysis at the 
time of initial transplantation evaluation.  Patients receiving dialysis were more likely to be 
black, lack a college education, report disability or unemployment, have a lower annual 
household income, and list Medicare as their medical insurance compared with patients not 
yet on dialysis therapy.  In an unadjusted Cox analysis, dialysis status at the time of the initial 
transplantation was associated with a slower rate of completion of the evaluation.  The 
association between dialysis status at the time of the initial transplantation evaluation and 
time to completion of the transplantation evaluation did not persist in the multivariable model 
(adjusted HR, 0.92; 95% CI, 0.60 to 1.42; P = 0.72).  After adjusting for other factors, black 
ethnicity remained associated with decreased rates of completion of the transplantation 
evaluation (adjusted HR, 0.63; 95% CI, 0.40 to 1.00; P = 0.05). 
 Weng et al. (2003) had a novel prospective recruitment of all patients who appeared 
for transplantation evaluation, regardless of patient dialysis status or availability of living 
donors.  Previous investigations of the transplantation process were restricted to patients 
either receiving maintenance dialysis (Alexander et al., 1998; Ayanian et al., 1999) or 
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seeking deceased donor transplants (Kasiske et al., 1998; Alexander et al., 2002).  The broad, 
inclusive criteria of Weng et al. (2005) permitted examination of the impacts of dialysis 
status and type of transplant donor, two factors that influence patient and allograft survival 
on completion of the transplantation evaluation.  These factors have not been previously 
studied extensively as determinants of access to transplantation.  Another novel feature of the 
study by Weng and coworkers (2005) is its focus on the medical evaluation for renal 
transplantation process.   
 Weng et al. (2005) admitted that the study had important limitations including, but 
not limited to, it’s possibly being underpowered to detect differences in the completion of the 
transplantation evaluation by dialysis and non-dialysis patients.  Second, because the study 
reflected the referral population of a single transplant center and the practices of the center’s 
transplant team, these results were not necessarily generalizable to other transplant centers.  
Third, although they collected information on many potential confounders, residual 
confounding remained a possibility.  In particular, they had limited ability to adjust for 
comorbidity and case-mix severity.  Specifically, greater comorbidity among blacks could 
have contributed to the slow rate at which blacks completed the transplantation evaluation.  
To minimize this confounding, they recorded the number and type of tests and evaluations 
requested by the transplant team.  After adjustment for these requested tests and evaluation, 
blacks still remained associated with decreased rates of completion of the transplant 
evaluation.  
 In summary, Weng et al. (2005) concluded that the completion of the medical 
evaluation for transplantation was unrelated to dialysis status.  The process was slower in 
blacks than whites and was associated with various socioeconomic factors.  Rapid 
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completion of the transplantation evaluation process would benefit all potential candidates 
for renal transplantation, irrespective of dialysis status or ethnicity.  Additional studies are 
needed to help determine the root causes of variations in completion of the medical 
evaluation and devise appropriate interventions (Powe & Boulware, 2002).  Interventions 
that expedite the medical evaluation while retaining its thoroughness may improve patient 
access to renal transplantation, increase rates of PKT, and possibly lead to better outcomes. 
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CHAPTER 3.  METHODOLOGY 
 
DATA OVERVIEW 
 The current research is a historical cohort study of all patients who experienced 
ESRD and/or received a cadaver kidney transplants between January 1, 2000 and December 
31, 2003.  The patients were identified using data acquired from the standard analytic files 
(SAF) of the USRDS.  Patients from the dataset were included in the study if they (1) were 
designated by CMS as having ESRD, (2) had their first ESRD service and/or underwent a 
cadaver kidney transplant between January 1, 2000 and December 31, 2003, (2) were either 
black or white, and (3) were not < 19 years old at the time of transplant.  Patients were 
excluded if they had more than one kidney transplant, or multi-organ transplants were 
obtained or if their transplants were obtained from living donors.   
 The data sources for this study were obtained from the 2000-2004 United States 
Renal Data System Database (USRDS) System.  The main objective of the USRDS database 
is to use all relevant ESRD data to create an integrated and consistent database system for 
outcomes research. The database includes ESRD patient demographic and diagnosis data, 
biochemical values, dialysis claims, and information on treatment history, hospitalization 
events, and physician/supplier services. 
 The data used by the USRDS originates from Center for Medicare Services (CMS), 
United Network for Organ Sharing (UNOS), the Centers for Disease Control (CDC), the End 
Stage Renal Disease (ESRD) Networks, and the USRDS special studies section.  The major 
source of ESRD patient information for the USRDS is the CMS Renal Beneficiary and 
Utilization System (REBUS), which was adopted in 1995 as the On-Line Transaction 
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Processing (OLTP) system from its predecessor, the Program Management and Medical 
Information System (PMMIS) database. The PMMIS/REBUS database contains 
demographic, diagnosis, and treatment history information for all Medicare beneficiaries 
with ESRD. 
 Data for input into the database that was utilized for this analysis was derived from 
the following sources that are summarized in the USRDS Researcher’s Guide (2005).   A 
quoted description of each from the Guide follows: 
• CMS Medical Evidence Form (CMS-2728)  
 
 The CMS Medical Evidence Form is completed by the renal provider 
for each new ESRD patient, and is sent to CMS through the ESRD Networks. 
It serves to establish Medicare eligibility for individuals who previously were 
not Medicare beneficiaries, reclassify previously eligible Medicare 
beneficiaries as ESRD patients, and provide demographic and diagnostic 
information on all new ESRD patients regardless of Medicare entitlement. 
Before 1995, dialysis units and transplant centers were required to file the 
Medical Evidence Report only for Medicare eligible patients. With the 
adoption of the newly revised form in 1995, however, providers are now 
required to complete the form for all new ESRD patients regardless of 
Medicare eligibility status. The revised form also contains new fields for 
comorbid conditions, employment status, race (the categories have been 
expanded), ethnicity, and biochemical data at the start of ESRD (USRDS 
Researcher’s Guide, 2005; 21). 
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• CMS ESRD Death Notification Form (CMS-2746) 
Like the Medical Evidence Report, the Death Notification Form is data 
rich, and its completion by renal providers is enforced by CMS. Providers 
usually have 45 days to report ESRD death events to their respective ESRD 
Networks, providing information about the place, time, and cause of death. 
Data are thus available to the USRDS Coordinating Center to conduct 
research on cause-specific mortality outcomes (USRDS Researcher’s Guide, 
2005; 21).   
• CMS Medicare Enrollment Database (EDB) 
 
The CMS Enrollment Database is the designated repository of all 
Medicare beneficiary enrollment and entitlement data, including current and 
historical information on beneficiary residence, Medicare as Secondary Payer 
(MSP) status, and Health Insurance Claim/Beneficiary Identification Code 
(HIC/BIC) cross-referencing (USRDS Researcher’s Guide, 2005; 21).  
• CMS Paid Claims Records 
 
Inpatient transplant and outpatient dialysis claims records are 
sometimes used to identify new ESRD patients for whom no Medical 
Evidence Report has been filed. These patients, who are most likely to be non-
Medicare patients or beneficiaries who develop ESRD while already on 
Medicare because of old age or disability, will eventually be entered into the 
PMMIS/REBUS database-and hence the USRDS-database through the claims 
records. For patients without Medical Evidence records, these claims are the 
only reliable information from which to determine first service dates for 
  49 
 
ESRD. These paid claims records, however, are only a supplement to-not a 
replacement of-other sources of information on incidence and prevalence 
(USRDS Researcher’s Guide, 2006; 21-22).  
• UNOS Transplant Database 
 
CMS began collecting data on all Medicare kidney transplants in the 
early 1980s. In 1988, UNOS was created to provide a national system for 
allocating donor organs and to maintain a centralized data depository on organ 
transplantation. UNOS also began collecting data on all transplants. 
Subsequently, these two collection efforts were consolidated in 1994, and 
UNOS became the sole source on transplant donors and recipients. The CMS 
and UNOS transplant data files overlap for 1988–1993, and some patients 
with Medical Evidence Reports indicating transplant as the initial modality are 
not included in either file. To resolve the conflicts among these three sources, 
the USRDS has adopted the following procedure: Prior to 1988 all transplant 
events found in CMS PMMIS/ REBUS Transplant files are used. After 1994, 
all transplant events found in the UNOS files are used.  Between 1988 and 
1993, all transplant events found in the UNOS files are used while additional 
transplant events are taken from the CMS PMMIS/REBUS Transplant file 
only if they occur at least 30 days (either side) of a previously accepted 
transplant event.  Additionally, transplant events associated with the reported 
incident transplant patients from the Medical Evidence Report (CMS-2728) 
are taken if they also occur at least 30 days (either side) of a previously 
accepted transplant event.  The transplant events found in the Transplant file 
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of the USRDS SAF Core CD are thus all unique events derived from the 
UNOS, CMS PMMIS/REBUS Transplant, and Medical Evidence record files 
(USRDS Researcher’s Guide, 2005; 21).  
• CMS ESRD Standard Analytical Files (SAFs) 
 
CMS SAFs contain data from final action claims, submitted by 
Medicare beneficiaries, in which all adjustments have been resolved. For Part 
A institutional claims, the USRDS uses the following 100% SAF claims: 
Inpatient 
Outpatient 
Skilled nursing facility (SNF) 
Home health agency (HHA) 
Hospice 
 
For Part-B physician/supplier 100% SAF claims: 
 
Physician/supplier 
Durable medical equipment (DME) 
 
CMS SAFs are updated each quarter through June of the next year, when the annual 
files are finalized. Datasets for the current year are created six months into the year 
and updated quarterly until finalized at 18 months, after which files are frozen and 
will not include late arriving claims. Annual files are thus approximately 98% 
complete. The USRDS 2005 ADR includes all claims up to December 31, 2003. 
Patient-specific demographic and diagnosis information, however, includes data as 
recent as October 2004 (USRDS Researcher’s Guide, 2005; 22).   
 The structure of the USRDS database is presented in Fig. 3-1.  
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Figure 3-1. Structure of the USRDS database.  
Source:  United States Renal Data System Researcher’s Guide to the USRDS Database. 
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney 
Diseases, Bethesda, MD, 2005.  Required notice:  “The data reported here [i.e., in this 
dissertation] have been supplied by the United States Renal Data System (USRDS).  The 
interpretation and reporting of these data are the responsibility of the author(s) and in no way 
should be seen as an official policy or interpretation of the U.S. government.” 
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PROTECTION OF HUMAN SUBJECTS 
 This study is a secondary data analysis of the USRDS database.  Prior to obtaining 
any data from USRDS/CMS, approval from Thee University of Tennessee Health Science 
Center Institutional Review Board (IRB) was obtained (see Appendix A). 
 
STATISTICAL ANALYSIS 
 The conceptual framework that guided the statistical analyses is depicted in Fig. 3-2. 
This framework begins with the race phenomenon being examined in the context of PKT. In 
outlining the knowledge state of ESRD the framework identifies the components, causes of 
ESRD and demographic characteristics that may play a part in the diagnosis of ESRD.  The  
diagnosis of ESRD leads to a referral to a nephrologists, which is the empirical phase of this 
research under examination and the theoretical fork in the road that leads either to a PKT or 
dialysis and/or placement on the transplant waiting list.  The framework identifies the  
pathway (depending on whether the patient receives a PKT or not) to whether the patient 
survives and or dies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2. Conceptual framework. 
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 Separate analyses were carried out for recipients of cadaver PKT and cadaver 
conventional kidney transplants grouped by patient’s race.  I first examined associations 
between patient characteristics listed in Fig. 3-2 and PKT or conventional kidney transplant, 
one variable at a time, assessing statistical significance with a ?? test (categorical data) or t 
test (continuous data).  A multivariate, logistic regression analysis was used to examine the 
relative influence of the variables.  This analysis was designed to assess which of the patient 
characteristics were independently associated with PKT and conventional kidney transplant.  
 The effect of race on PKT and conventional kidney transplant was also examined, for 
graft and patient survival using the Kaplan-Meier method with a log-rank test for statistical 
significance.  All analysis was carried out using the statistical software package SAS version 
9.1.4 (SAS Institute, Inc., Cary, NC).  All results were considered statistically significant if P 
< 0.05.  
 
KEY CONCEPTS IN ESRD 
 
Who Is an ESRD Patient? 
An ESRD patient is one who has developed chronic renal failure and requires kidney 
replacement treatment, dialysis or transplant to sustain life.  This is not to be confused with 
acute renal failure, in which the patient is expected to recover renal function after several 
weeks or months. Those patients who experience acute renal failure and are on dialysis for 
days or weeks, but who subsequently recover kidney function, are, as much as possible, 
excluded from the ESRD database. A person is identified as having ESRD when a physician 
certifies the disease on a medical evidence form (CMS 2728), or when there is other evidence 
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that the person has received chronic dialysis or a kidney transplant. The medical evidence 
form is completed by renal a renal provider, not only to register the patients in the CMS 
ESRD database, but also to apply for their Medicare eligibility if they have not previously 
been eligible. Patients who die soon after kidney failure without receiving dialysis treatment 
are occasionally missed (USRDS Researcher’s Guide, 2005). 
 
First ESRD Service Date 
The first ESRD service date (FSD) is the single most important data element in the 
USRDS database, and each patient must, at a minimum, have a valid FSD. This date is used 
to determine the incident year of each new patient and the first year in which the patient is 
counted as prevalent. The date 90 days after the FSD is used as the starting point for most 
patient survival outcomes analyses. This special rule is necessary for all ESRD patients, who 
are covered by Medicare as payer, to be given a fair chance of generating Medical services 
due to potential delay of the Medicare eligibility application process. Furthermore, it also 
provides an adequate time window for each patient to finally settle on a stable and suitable 
dialytic treatment modality. The FSD is derived by taking the earliest of the date of the start 
of dialysis for chronic renal failure, as reported on the Medical Evidence form, the date of a 
kidney transplant, as reported on a CMS or UNOS transplant form, a Medical Evidence form, 
or a hospital inpatient claim, or the date of the first Medicare dialysis claim. Most FSDs are 
derived from the Medical Evidence form. In the absence of this form, the date of the first 
Medicare dialysis claim or transplantation usually supplies the FSD.  
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 In the few cases in which the date of the earliest dialysis claim is earlier than the first 
dialysis date reported on the Medical Evidence form, the earliest claim date is used as the 
FSD. To establish the date of first ESRD service information in several data sources must be  
evaluated. REBUS contains the first ESRD service date in its identification record in the 
Medical Evidence record. The REBUS Quarterly Dialysis record is a summary of dialysis 
billing information, and can also be used to establish first ESRD service date in the event of 
missing data in other files. Finally, information on the first service date for incident 
transplant patients is obtained from the UNOS transplant dataset. Data from these sources is 
combined to establish the first ESRD service date (USRDS Researcher’s Guide, 2005). 
 
Preemptive Kidney Transplantation 
If the time between the date of ESRD and transplantation was 6 months or less, then 
the transplant was considered to be preemptive. Otherwise, the transplant was non-
preemptive.  
 
 Incidence and Prevalence 
Incidence is defined as the number of people in a population newly diagnosed with a 
disease in a given time period, typically a year, while prevalence is the number of people in a 
population who have the disease at a given point in time (point prevalence) or during a given 
time period (period prevalence). The USRDS generally reports point prevalence, which is the 
type of prevalence used primarily throughout the ADR as of December 31, 2005.  Period 
prevalence is reported for a calendar year. Annual period prevalent data consist both of 
people who have the disease at the end of the year and those who had the disease during the 
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year and died before the year’s end. The USRDS treats successful transplantation as a 
therapy rather than as a “recovery” from ESRD. Patients transplanted at the time of ESRD 
initiation are counted as incident patients, while those with a functioning transplant are 
counted as prevalent. Because data are available only for patients whose ESRD therapy is 
reported to CMS, patients who die of ESRD before receiving treatment or whose therapy is 
not reported to CMS are not included in the database. The terms incidence and prevalence are 
thus qualified as incidence and prevalence of reported ESRD. Some ESRD registries, such as 
the European Dialysis and Transplantation Association, use the term “acceptance into ESRD 
therapy.” The USRDS, however, believes that “incidence of reported ESRD therapy” is more 
precise, because “acceptance” implies that remaining patients are rejected, when in fact they 
may simply not be identified as ESRD cases or may not be reported to CMS. Point 
prevalence is a useful measure for public health research, since it measures the current 
burden of the disease on the health care delivery system, and period prevalence is appropriate 
for cost analysis, since it indicates the total disease burden over the course of the year. We 
have chosen, however, to focus primarily on the incidence of ESRD, believing that it is the 
most useful measure for medical and epidemiological research that examines disease 
causality and its effect on different sub-populations (USRDS Researcher’s Guide, 2005). 
 
TRANSPLANT FAILURE 
 It is generally assumed that the graft failure date reported in the UNOS Transplant 
Follow-up file or the REBUS Identification file is correct unless death or a new transplant 
occur before this date. It is possible, however, for a transplant failure date to go unrecorded 
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in both files. In the absence of a transplant failure date, the USRDS derives the transplant 
failure date from the following sources: 
• Date of death. 
• Date of subsequent transplant. 
• The date of return to regular dialysis, indicated by a continuous period of dialysis 
billing records covering a minimum of 60 days with at least 22 reported dialysis 
treatments.  
• Date of return to dialysis reported on the Medical Evidence form, or the date of      
graft nephrectomy from either the UNOS transplant follow-up record or a Medicare 
claim.  
• If no failure date is available, then the earliest of the above dates is used as the 
transplant failure date (USRDS Researcher’s Guide, 2005). 
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CHAPTER 4.  RESULTS 
 
 This historical cohort study investigates whether there were inequities in the 
allocation of cadaver kidneys for preemptive kidney transplants (PKT) between blacks and 
whites.  This issue is important because PKT has established itself as an attractive alternative 
to post dialysis conventional kidney transplantation (Asderakis, et al., 1998).  PKT not only 
avoids the risks, costs, inconvenience and diminished quality of life of dialysis but has also 
been significantly associated with better graft and patient survival than transplantation after a 
period of dialysis.  Numerous studies have provided convincing evidence that PKT is 
advantageous for patient and allograft survival (Mange and Weir, 2003).  The significance to 
the patients, specifically blacks, of the under utilization of PKT and the overlooked 
opportunities for the avoidance of dialysis associated morbidities and improved graft and 
patient survival may be substantial.  The research observation that whites and persons with 
higher incomes in the United States are more likely to be placed on the cadaveric waiting list 
before dialysis initiation and receive a PKT might suggest some systemic bias (Kasiske, et 
al., 2002).  Examination of the 10,067 cadaver kidney transplant recipients that occurred 
between January 1, 2000 and December 31, 2003 allowed me to determine whether there was 
a disparity between blacks and whites with respect to the likelihood of their receiving  
cadaver kidneys for PKT. 
  This investigation used descriptive statistics and multivariate analyses to identify 
factors associated with whether a patient received a PKT or a conventional, post dialysis 
kidney transplant. Through the examination of the descriptive statistics, a comparison of the 
frequencies and percentages of PKT versus conventional post dialysis transplants between 
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blacks versus whites was made.  The multivariate analysis was used for the identification of 
factors associated with differences that may exist and also allowed for a determination of the 
statistical significance of any differences that may exist, after controlling for variables such 
as age, sex, employment, primary conditions leading to ESRD and health insurance. The 
conceptual framework (Fig. 3-2) guided the inclusion of variables used in the statistical 
analysis.  The conceptual framework reflects the relationships among the variables linking 
the independent variable to the dependent variables and serves to clarify the research 
problem relating to the allocation of either preemptive or conventional cadaver kidneys.   
 While the primary focus of this research was those transplant recipients who received 
a PKT, an overview of the ESRD population was provided, because the analysis of this 
population that allowed determinations as to whether the current system, policies and 
practices relating to the allocation of kidneys leads to an outcome that is proportionally 
reflective of the ESRD population.    
 The combination of the SAF, UNOS kidney transplant and the medical evidence form 
files resulted in a total of 1,600,693 CMS patient records (Fig. 4-1).  From the 
aforementioned total, 1,513,366 of all CMS patients at least 19 years of age for the 4 year 
study period were designated as having ESRD.  This group was made up of 459,746 
(30.38%) black and 1,053,620 (69.62%) whites.  Patients were designated as having ESRD 
when a physician certifies the disease on the medical evidence form (CMS 2728) or when 
there was other evidence that the person has received chronic dialysis or a kidney transplant.   
 Of the total number of patients being certified as having ESRD during the study 
period, 397,656 (92%) did not receive a transplant.  Noteworthy is the fact that 151,926 
(38%) of those not receiving a transplant died during the 4 year study period and only 4.5%  
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Figure 4-1. Flow chart of patients from entry into Center for Medicare Services 
System via standard analytical files through either PKT or conventional cadaver kidney 
transplant. 
ESRD diagnosed patients 
1,513,366 
Black – 459,746 – (30.38%) 
White – 1,053,620 – (69.62%) 
Cadaver Transplants   
10,067 
Blacks – 1,962 – (19.49%) 
Whites – 8,105 – (80.51%) 
 
CMS SAF Patient File 
1,600,693 
 
 
ESRD 1/1/2000-12/31/2004 
434,329 
Black – 131,837 – (30.35%) 
White – 302,555 –(69.65%) 
No Transplant 
Black – 125,089 (31.46%) 
Died – 38,290 (30.61%) 
White – 272,567 (68.54%) 
Died – 113,636(41.69) 
First Kidney Only Transplant 
31,703 
Black – 5,498 (14.34%) 
White – 26,205 (86.66%) 
PKT 3,038 (30.18%) 
Blacks-327-(10.67%) 
Whites-2,711-(89.24%) 
Conventional 7,029 (69.82%) 
Blacks – 1,635 – (23.26%) 
Whites – 5,394 – (76.74%) 
Lived 
Black-1,572 (96.15%) 
White-5,135 (95.2%) 
Lived 
Black-309 (94.5%) 
White-2,591 (95.58%) 
Died 
Black-18 (5.50%) 
White-120 (4.43%) 
Died 
Black-63 (3.86%) 
White-259 (4.8%) 
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of those receiving a transplant died.  In the group of ESRD patients not receiving a transplant 
and dying during the study period 30.61% (38,290) were black and 41.69%(113,636) were 
white.  A total of 245,730 (61%) of those not receiving a transplant remained alive for the 
duration of the four year study period.  
 From the total of 434,329 black and white patients at least 19 years of age diagnosed 
with ESRD only 31,703 (7.45%) patients received kidney transplants during the study period.  
Included in this total were recipients who received multiple transplants, living donor 
transplant recipients, cadaver donor transplant recipients, preemptive, and conventional 
transplant recipients. Of those in the ESRD population that received transplants only 5,498 
(17.34%) were black and 26,205 (83%) were white.  
 Because the study period was from January 1, 2000 through December 31, 2003, 
ESRD patients who were either diagnosed or had their first dialysis or transplant before 
January 1, 2000, were excluded from this analysis.  Patients who received a transplant 
subsequent to the conclusion of the study period, December 31, 2003 were also excluded.  
The total population of transplant recipients during the study period who were at least 19 
years of age at the time of their first ESRD service during the study period and received their 
first time only either PKT or conventional cadaver transplant during the study period was 
10,067 (32.%) of the 32,703 kidney transplant recipients.   
 This isolated population of 10,067 cadaver transplant recipients was the sample 
subjected to further analysis for this investigation.  This sample was comprised of 1,962 
(19.49%) black receiving cadaver transplants and 8,105 (80.51%) whites.  Of the blacks 
receiving cadaver transplants, 327 (11%) received a PKT and 1,635(23%) received 
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conventional transplants.  Among whites who received cadaver kidney transplants, 
2,711(89%) received a PKT and 5,394(75%) received a conventional cadaver transplants.  
 As reflected in Table 4-1, the largest number of patients meeting study 
inclusion/exclusion criteria came from the 2000 cohort with decreasing numbers throughout 
the remaining years of the study period.  Table 4-2, which shows the year and frequency of 
transplants performed reflects continued increases in the number of transplants that were 
performed annually.  Explanations for both trends include simple increases in the number of 
conventional transplants as a result of individuals spending more time on the transplant 
waiting list and/or increases in the number of PKTs.  
 
REGION OF TRANSPLANT 
 The transplant population examined in this investigation was distributed across the 11 
organ procurement regions as defined by UNOS (Table 4-3).  Most transplants took place in 
region 3 which was closely followed by region 2.  Region 3 led the country with most 
conventional transplants and was a close second in PKTs.  Approximately 25% of the PKTs 
received by blacks occurred in organ procurement region 2 followed by over 20% of those 
residing in region 3 (Table 4-4).  Blacks in region 2 received conventional kidney transplants 
at slightly lower rates, while whites received approximately the same rates of 14% for both 
PKT and conventional transplants in regions 2 and 3 respectively.  The cautionary 
admonishment offered regarding the regional variations in cadaveric kidney transplant 
frequency reflected in Tables 4-3 and 4-4 is that it is dependent
 
on many factors, including 
cadaveric organ availability, local competition for supply including
 
ESRD prevalence, access 
to the transplant evaluation process,
 
and the relative frequencies of donor-recipient pool 
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Table 4-1. Year of first ESRD service for 10,067 patients included in the current 
cohort. 
 
 
Year 
ESRD  
Frequency 
 
Cumulative Frequency 
2000 
2001 
2002 
2003 
4553 
3042 
1764 
708 
4553 
7595 
9359 
10067 
 
 
 
Table 4-2. Year of transplant, frequency, percentage and cumulative frequency and 
percentage by year. 
 
 
Year 
 
Frequency 
 
Percent 
Cumulative 
Frequency 
 
Cumulative Percent 
2000 869 8.63 869 8.63 
2001 2045 20.31 2914 28.95 
2002 3379 33.57 6293 62.51 
2003 3774 37.49 10067 100 
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Table 4-3.  Frequency and percentage of PKT and conventional transplant recipients 
by regionb. 
 
 
Region 
Total 
Frequency
a 
PKT 
 Frequency 
Conventional 
Frequency 
 
Percent (%) 
1 391 86 305 3.92 
2 1468 448 1020 14.71 
3 1598 447 1151 16.10 
4 869 186 683 8.71 
5 1064 344 720 10.66 
6 412 115 297 4.13 
7 1070 406 664 10.72 
8 636 187 449 6.37 
9 476 155 321 4.77 
10 1014 284 730 10.16 
11 983 295 688 9.85 
 
a. Frequency missing = 86  
 
b. Region 1 – CT, VT, ME, MA, NH, RI 
 Region 2 – DE, DC, MD, NJ, PA, WV 
Region 3 – AL, AR, FL, GA, LA, MS, PR (U.S. Caribbean Islands and Virgin Islands) 
 Region 4 – TX, OK 
 Region 5 – AZ, CA, NV, NM, UT 
 Region 6 – AK, HI, ID, MT, OR, WA 
 Region 7 – IL, MN, ND, SD, WI 
 Region 8 – CO, IA, KS, MO, NE, WY 
 Region 9 – NY 
 Region 10 – IN, MI, OH 
 Region 11 – KY, NC, SC, TN, VA 
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Table 4-4. Frequencya and percentage of PKT and conventional kidney transplant 
recipients by regionb and by race. 
           
 PKT Conventional 
Region Black % (n) White % (n) Black % (n) White % (n) 
1 5(1.60) 81(3.07) 38(2.32) 267(4.95) 
2 80(25.64) 368(13.93) 289(17.68) 731(13.55) 
3 64(20.51) 383(14.50) 375(22.94) 776(14.39) 
4 10(3.21) 176(6.66) 161(9.85) 522(9.68) 
5 19(6.09) 325(12.31) 80(4.89) 640(11.87) 
6 2(0.64) 113(4.28) 22(1.35) 275(5.10) 
7 24(7.69) 382(14.46) 142(8.69) 522(9.68) 
8 8(2.56) 179(6.78) 57(3.49) 392(7.27) 
9 22(7.05) 133(5.04) 79(4.83) 242(4.49) 
10 36(11.54) 248(9.39) 171(10.46) 559(10.37) 
11 42(13.46) 253(9.58) 221(13.52) 467(8.66) 
Total 312            2,641  1,635          5,393 
 
a. Frequency missing = 86 due to missing data 
 
b Region 1 – CT, VT, ME, MA, NH., RI 
 Region 2 – DE., DC, MD., NJ, PA., WV 
Region 3 – AL, AR., FL, GA, LA, MS, PR (U.S. Caribbean Islands and Virgin Islands) 
 Region 4 – TX, OK 
 Region 5 – AZ, CA, NV, NM, UT 
 Region 6 – AK, HI, ID, MT, OR, WA 
 Region 7 – IL, MN, ND, SD, WI 
 Region 8 – CO, IA, KS, MO, NE, WY 
 Region 9 – NY 
 Region 10 – IN, MI, OH 
 Region 11 – KY, NC, SC, TN, VA 
 
 
  66 
 
biologic
 
incompatibilities that may affect status on a given match-run Nonetheless,
 
the 
existence of these variations, whether they are real or apparent,
 
suggests that the allocation of 
organs for transplantation in
 
the United States is not uniform across all regions.  
 
CHARACTERISTICS OF PREEMPTIVE AND CONVENTIONAL TRANSPLANT 
RECIPIENTS 
 Over a period of four years, January 1, 2000 through December 31, 2003, a total of 
10,067 patients experienced ESRD and received primary kidney-only cadaver donor 
transplants.  Overall, 30.18% (3,038) of these 10,067 transplants were PKT (Table 4-5). The 
remaining 69.82% (7,029) make up the conventional kidney transplant group of patients who 
were transplanted after having been treated by hemodialysis or continuous ambulatory 
peritoneal dialysis (CAPD) for six months or longer.  Blacks accounted for 10.76% (327) of 
the PKT recipients and 23.26% (1635) of the conventional transplants, with an overall rate of 
19.49% (1962) of the 10,067 patients who received cadaver transplants. Whites accounted 
for 89.24% (2,711) of the PKT group and 76.74% of the conventional transplant group.  
Overall, whites accounted for 80.51% of the patients who received cadaver transplants during  
 
Table 4-5. Frequency of PKT and conventional transplants occurring between 
January 1, 2000 and December 31, 2003 among patients who developed ESRD during 
the same time period, according to gender and race. 
            
                    PKT   Conventional   Total 
 
Black  
327(10.76%) 
White 
2711(89.24%) 
Black 
1635(23.26%) 
White 
5394(76.74%)    
Male 56.27 57.62 59.69 63.27  57.47% 
Female 43.73 42.38 40.31 36.73  42.53% 
 Total       3038 (30.18%)     729 (69.82%)               10,067 
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the study period.  Overall, males (57.47%) received preemptive kidney transplants more 
frequently than females (42.53%).  Likewise, more males received conventional transplants 
(62.44%) than females (37.56%).    
 
Age 
 The mean age for all black transplant recipients in this cohort was 47.7 years of age 
compared to 49.8 years of age for white transplant recipients across all groups.  For all PKT 
recipients the mean age was 49.1 years compared with a mean age of 48.4 years for all 
conventional transplant recipients.  Black PKT recipients had a mean age of 48.4 years of age 
(Table 4-6) while their white PKT counterparts were almost a year older at 49.8 years of age, 
indicating that, for blacks who did receive a PKT, they did so at a younger age, on average, 
than did their white counterparts.  Black conventional transplant recipients at an average of 
47 years of age were also younger than their white conventional transplant recipient peers.  
Overall, blacks received transplants at younger ages than whites. Across all groups, 
transplants were more likely among recipients aged 40 through 64 (Table 4-7).   At least 1 
black PKT patient was over 77 years of age and 3 white PKT patients were over 82 years of 
age at the time of their transplant.  There was at least 1 black transplant recipient who 
received a conventional kidney transplant at 79 years of age and at least 5 white transplant 
recipients who were over 82 years old at the time of their transplant.   
 
Employment   
 PKT recipients were more likely than conventional kidney transplant recipients to be 
employed full-time (Table 4-8).  It is not difficult to understand that patients who are not yet 
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Table 4-6.  Mean age in years of patients by race receiving either a PKT or 
conventional kidney transplant between January 1, 2000 and December 31, 2003. 
 
Transplant 
Type 
  
N 
 
Mean ( yr) 
 
Std. Error (yr) 
Preemptive Black 327 48.4 0.69 
 White 2711 49.8 0.23 
Conventional     
 Black 1635 47.0 0.31 
 White 5394 49.9 0.17 
Total      10,067   
     
 
 
 
Table 4-7.  Age category at first ESRD service and kidney transplant frequency 
included in the current cohort. 
 
Age Category Frequency Percent(%) 
19 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
43 
272 
467 
731 
888 
1123 
1441 
0.43 
2.70 
4.64 
7.26 
8.82 
11.16 
14.31 
50-54 1541 15.31 
55-59 1350 13.41 
60-64 1102 10.95 
65-69 734 7.29 
70-74 290 2.88 
75-79 
80-84 
76 
9 
0.75 
0.09 
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Table 4-8. Employment status in percentages of PKT and conventional transplant 
recipients by race. 
                   
 PKT                  Conventional 
Current 
Employment 
Status 
Black 
(n = 226) 
 
White 
(n = 2,037) 
 
Black 
(n = 1,541) 
 
White 
(n = 5,127) 
 
Unemployed 42(18.58) 337(16.54) 397(25.76) 878(17.13) 
Employed 
Full-Time 79(34.96) 756(37.11) 441(28.62) 1,566(30.54) 
Employed 
Part-Time 4(1.77) 114(5.60) 54(3.50) 232(4.53) 
Homemaker 3(1.33) 96(4.71) 31(2.01) 236(4.60) 
Ret-Age 25(11.06) 234(11.49) 158(10.25) 740(14.43) 
Ret-Disab 43(19.03) 321(15.76) 305(19.79) 1,055(20.58) 
Med LOA 24(10.62) 166(8.15) 137(8.89) 380(7.41) 
Student 6(2.65) 13(0.64) 18(1.17) 40(0.78) 
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on dialysis may be better able to work full-time, because dialysis can make it difficult to 
maintain full-time employment.  Another potential advantage of PKT may be allowing at 
least some individuals to continue to work. White PKT recipients were more likely to be 
employed full-time at 37.11% (756) compared to 34.96% (79) for blacks.  Black PKT 
patients were slightly more likely to report being unemployed at 18.58% (42) when 
compared to white PKT recipients at 16.54% (337).  White PKT recipients also reported 
higher rates of part-time employment 5.60% (114), being homemakers 4.71% (96), and being 
retired at 11.49% (234) than did black PKT recipients.  Black patients did have higher 
percentages of retired disabled at 19.03% (43), those on medical leave of absence at 10.62% 
(24) and students at 2.65% (6).  Black conventional kidney transplant recipients reported 
being unemployed at a rate much higher than that of white conventional transplant recipients 
25.76% (397) compared to 17.13% (878) for whites.  Whites reported higher rates of 
employment, 30.54% (1566), part-time employment, 4.53% (232), being homemakers, 
4.60% (236), being of retirement age, 14.43% (740), and retirement disabled at 20.58% 
(1055) and students at 1.17%.  For black conventional kidney transplant recipients 
unemployment, 25.76% and those on a medical leave of absence, 8.89%, were the only 
categories in which the percentages of blacks exceeded those of whites.  There were not any 
differences in employment status between blacks and whites for either PKT or conventional 
recipients. 
 
CAUSES OF ESRD   
Overall, the leading cause of ESRD for this cohort was diabetes, followed by 
hypertension (renal disease caused by hypertension with no primary renal disease), 
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glomerulonephritis, and cystic kidney disease (Table 4-9). In the black PKT population, the 
causes listed as leading to ESRD were diabetes 21.71% (71) and hypertension 19.88% (65) 
and for black conventional kidney transplant recipients both diabetes 34.43% (563) and 
hypertension 32.42% (563) remained the leading causes of ESRD.  In white PKT patients the 
leading causes of their ESRD were diabetes at 30.51% (827), glomerulonephritis 13.32% 
(361), and cystic kidney disease 13.24% (359).  In white PKT patients hypertension was 
listed as the cause of ESRD for only 7.49% (203) of the recipients.  For white conventional 
transplant recipients diabetes remained the dominant cause of ESRD at 39.19% (2114) with 
glomerulonephritis remaining second at 20.47% (1104).  There were differences between the 
PKT recipients and the conventional transplant recipients across the 3 major causes of ESRD, 
diabetes, hypertension and glomerulonephritis.   
 
KIDNEY DONOR RACE 
 Overall 89.24% (n=2,711) of the donor kidneys received by PKT recipients and 
76.74% (n=5,394) of those received by conventional transplant recipients were obtained from 
white cadaver donors (Table 4-10).  Black PKT patients received 69.42% (n=227) of their 
kidneys from white donors and 17.43% (57) from blacks. White PKT patients received 
5.94% (161) from black donors with the bulk of their PKT donations (77.61% (n=2,104) 
coming from other white donors.  Among the 1,635 black conventional transplant recipients, 
16.39% (n=268) of the kidneys came from black donors and 68.87% (n=1,126) came from  
white donors.  Black donors were responsible for 5.82% (n=314) of the organ donations to  
whites, with other whites contributing 77.29% (n=4,169).  More black cadaver donor kidneys 
were transplanted into whites than into black kidney recipients.  Thus despite a greater 
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Table 4-9. Primary disease causes of ESRD in frequency and percentages of PKT and 
conventional kidney transplant recipient, by race. 
 
  
 
PKT   
 
Conventional  
  Primary Disease  
  Category 
Black 
n=327 
(10.76) 
White 
n=2,711(89.24) 
Black 
n=1,635(23.36) 
White 
n=5,394 
(76.74) 
71(21.71) 827(30.51) 563(34.43) 2,114(39.19) 
65(19.88) 203(7.49) 530(32.42) 699(12.96) 
45(13.76) 361(13.32) 301(18.41) 1,104(20.47) 
21(6.42) 359(13.24) 56(3.43) 662(12.27) 
20(6.12) 130(4.80) 18(1.10) 153(2.84) 
32(9.79) 351(12.95) 98(5.99) 482(8.94) 
15(4.59) 148(5.46) 67(4.10) 179(3.32) 
Diabetes 
Hypertension 
Glomerulonephritis 
Cystic Kidney 
Other Urologic 
Other cause 
Unknown Cause 
  
Missing Cause 58(17.74) 332(12.25) 2(0.12) 1(0.02) 
 
 
Table 4-10. Kidney donor race in frequency and percentages of PKT and conventional 
kidney only transplant recipients.
 
       
 
 
PKT Conventional 
Donor Race 
Black 
(n=218) 
White 
(n=2,331) 
Black 
(n=582) 
White 
(n=5,295) 
Asian 4(1.22) 31(1.14) 19(1.16) 72(1.33) 
Black 57(17.43) 161(5.94) 268(16.39) 314(5.82) 
White 227(69.42) 2,104(77.61) 1,126(68.87) 4,169(77.29) 
Other/Unknown 39(11.93) 394(14.86) 221(13.52) 823(15.26) 
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 percentage of the kidneys from black donors being transplanted into white recipients, the 
overwhelming majority of the available organs were obtained from white donors. 
 
 
PATIENT OUTCOMES FOR PKT AND CONVENTIONAL KIDNEY TRANSPLANT 
RECIPIENTS  
 The association among race, PKT, conventional kidney transplantation, and outcomes 
were analyzed based on four measures assessed on December 31, 2003: alive with 
functioning graft, alive without functioning graft, died with a functioning graft and died after 
graft loss (Table 4-11).  Among black recipients those alive with functioning grafts from 
either PKT or conventional transplants, were 81.65% and 84.04%, respectively.  There was a 
slightly higher percentage of black conventional kidney transplant recipients alive with 
functioning grafts than there were PKT recipients. For those alive without functioning grafts 
blacks had approximately 12% of both PKT and conventional kidney transplant recipients.  
Fewer blacks with a PKT died after graft loss, 0.92% than did conventional kidney transplant 
recipients with 1.35%.  However, the percentage of PKT blacks that died with a functioning 
graft, 4.59%, was more than that of blacks with conventional kidney transplants (2.51%).   
 As was the case with blacks, whites with conventional kidney transplants had a 
slightly better percentage of those surviving with a functioning graft than did the PKT 
recipients. More PKT whites survived with graft loss than did white conventional kidney 
transplant recipients but fewer white PKT recipients died after graft loss (0.63%) than did 
conventional kidney transplant recipients (1.11%).  A slightly larger percentage of white 
PKT recipients died with a functioning graft (3.80%) than did white conventional kidney 
transplant recipients (3.69%).        
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Table 4-11. Percentages and frequencies for various outcomes for patients receiving a 
PKT or conventional transplant
a
. 
 
  
PKT 
b                                  
 
Conventional
c
 
Outcome Black 
(n=327) 
White 
(n=2711) 
Black 
(n=1635) 
White 
(n=5394) 
Alive with 
functioning graft 
267(81.65) 2,356(86.91) 1,374(84.04) 4,722(87.54) 
Alive with graft 
loss 
42(12.84) 235(8.67) 198(12.11) 413(7.66) 
Died after graft loss 3(0.92) 17(0.63) 22(1.35) 60(1.11) 
Died with 
functioning graft 
15(4.59) 103(3.80) 41(2.51) 199(3.69) 
 
a. The cohort consisted of all patients who experienced ESRD and/or received a cadaver 
kidney transplant between January 1, 2000 and December 31, 2003. 
b. No significant difference was detected between blacks and whites with respect to the 4 
outcome groups (p<.0615). 
c. A significant difference was detected between blacks and whites with respect to the 4 
outcome groups (p<.0001). 
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 A larger proportion of white PKT recipients (86.9%) lived with functioning grafts 
compared to black PKT transplant recipients (81.65%); however, a larger proportion of black 
PKT recipients were alive after graft loss (12.84%) compared to white PKT recipients 
(12.11%).  A smaller proportion of white PKT recipients died after graft loss (0.63%) than 
black PKT recipients (0.92%).  A larger proportion of blacks PKT recipients died with a 
functioning graft (4.59%) than did white (3.80%) PKT recipients.  Outcomes for white 
conventional kidney transplant recipients were similar to those of the PKT group with the 
marked exception of those who died with a functioning graft.  White conventional kidney 
transplant recipients died with greater frequency (3.69%) when compared to blacks 
conventional transplant recipients (2.51%). 
 
TIME TO TRANSPLANTATION 
 For the 327 black PKT recipients the median elapsed time from first service for 
dialysis to transplantation was 1 day (mean ± se: 1.0894 ± 0.0966 months) compared to black 
conventional transplant recipients whose median elapsed time was 22.47 months (mean ± se: 
23.2178 ± 0.25 months).  The mean time for the 2711 white PKT recipients was, as it was 
with the PKT blacks, 1 day (mean ± se: 1.0941 ± 0.0342 months).  White conventional 
kidney transplant recipients had a median elapsed time of 18.29 months (mean ± 19.7203 ± 
0.1261 months) (Table 4-12).  Although black and white PKT recipients both had a median 
elapsed time of 1 day as their elapsed time from first service for dialysis and their kidney 
transplant, there was a difference of approximately 4 months waiting time between blacks 
and whites receiving conventional kidney transplants.  
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Table 4-12.  Racial disparity in elapsed time from first service for dialysis and 
transplantation.  
 
Type 
Transplant 
 
Race 
No. of 
Patients 
 
Mean (Mo) 
Median 
(Mo) 
Std. Error 
(Mo) 
Preemptive      
 Black 327 1.09 0.032 0.09 
 White 2711 1.09 0.32 0.03 
Conventional      
 Black 1635 23.21 22.47 0.24 
 White 5394 19.72 18.29 0.12 
 
 
 
MULTIVARIATE ANALYSIS  
For all cadaver transplant recipients in the study cohort, the odds of receiving a 
preemptive kidney transplant were 2.5 times greater for whites than for blacks (Table 4-13).   
This result was statistically significant.  For this same cohort the odds of receiving a 
preemptive kidney transplant were 23% greater for females compared with males. This result 
was also statistically significant.  Compared with those patients who had a diagnosis of 
hypertension as the primary cause for their ESRD, a patient was more than twice as likely to 
receive a preemptive transplant if they had a diagnosis that indicated that their ESRD was 
primarily caused by something other than hypertension.  Compared to patients who had a 
diagnosis of diabetes as the primary cause of their ESRD, those who did not have that 
diagnosis had a 46% greater likelihood of getting a preemptive kidney transplant.  Compared 
with patients who had a diagnosis of glomerulonephritis as the primary cause of their ESRD 
those patients who did not have that diagnosis had a 62% greater likelihood of getting a 
preemptive kidney transplant.   
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Table 4-13.  Recipient characteristics associated with preemptive kidney 
transplantationa. 
             
 
Variable 
 
Reference Group 
Odds Ratio 
(95% CI) 
 
P value 
Black White 0.3979 
(0.35 to 0.45) 
<0.0001 
Female Male 1.230 
(1.12 to 1.34) 
<0.0016 
Not-Hypertension Hypertension
b 
2.190 
(1.90 to 2.51) 
<0.0001 
Not-Diabetes Diabetes
b 
1.465 
(1.33 to 1.60) 
<0.0001 
Not-
Glomerulonephritis 
Glomerulonephritis
b 
1.619 
(1.43 to 1.82) 
<0.0001 
 
a. Odds rations and confidence limits were estimated from 2x2 contingency tables. 
b. As the cause of ESRD. 
 
  
 Although the analysis reflected in Table 4-13 shows race and other variables are 
significantly related to receiving a PKT, the analysis must be carried further to demonstrate a 
disparity.  These differences reflected at this point do not demonstrate a disparity between 
blacks and whites in the rates in which they receive PKTs.  In a broad context, we think of 
health disparities as the population specific differences in the presence of disease, health 
outcomes or access to health care.  Health Disparities, as defined by the Institute of 
Medicine’s Committee on Understanding and Eliminating Racial and Ethnic Disparities in 
Health Care, are racial and ethnic differences in the quality of health care that are not due to 
access-related factors or clinical needs, preferences, or appropriateness of the intervention 
(IOM, 2003). 
Although every member in the cohort had access to Medicare they all did not use 
Medicare for their ESRD treatment and/or transplant.  All insurance is not the same 
insurance. That is to say that all insurance does not afford the same level of access.  
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Therefore to determine if there was a true disparity between blacks and whites in PKT it is 
necessary to control for access in order to balance the variables that may give one group an 
advantage over the other in access to PKT.  To do so, a subset of the cohort (n=847)—only 
those utilizing Medicare Parts A and B—was subjected to the multivariate analysis in order 
determine if the significance of the aforementioned variables goes further to demonstrate  
that there was actually a disparity between blacks and whites relative to receipt of PKT  
(Table 4-14).  As reflected in Table 4-14 race and the aforementioned comorbid conditions 
of hypertension, diabetes, and glomerulonephritis remained statistically significant, similar to 
the findings reported in Table 4-13. For those in the subset cohort, the odds of receiving a 
preemptive kidney transplant were almost 60% less likely for blacks than for whites (Table 
4-14). Those in this subset cohort had 15% greater odds for a PKT if they were females 
compared to males, which was a lower odds ratio than in the overall cohort. Compared with 
those patients who had a diagnosis of hypertension, diabetes or glomerulonephritis as the 
primary cause for their ESRD a patient had 80%, 50%, and 24% respectively greater odds of 
getting a preemptive transplant if they had a diagnosis that indicated that one of these was not 
the primary cause of their ESRD.   
A second strategy was used to again control for the role of access in PKT receipt.  
The full cohort was subjected to a final expanded multivariate analysis, which included two 
insurance variables—those with Medicare, both parts A and B—and those with Medicare as 
the secondary payer (Table 4-15). The employment variable was also included in this 
analysis to test for its effect on the likelihood of receiving a PKT.  These results remained 
consistent with the previous two analyses (Tables 4-13 and 4-14) with race, hypertension,  
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Table 4-14.  Medicare A and B only recipient characteristics associated with preemptive 
kidney transplantation. 
 
 
Variable 
Reference 
 Group 
Odds Ratio 
(95% CI) 
 
P value 
Age 40 to 55 Age > 55 1.000 
(0.989 to 1.010) 
0.9508 
Black White 0.4294 
(0.2945 to 0.6261) 
0.0002 
Female Male 1.1474 
(0.8671 to 1.5184) 
0.5322 
Non-Hypertension Hypertension 1.8050 
(1.2095 to 2.6973) 
<.0001 
Non-Diabetes Diabetes 1.4976 
(1.1177 to 2.0065) 
<.0001 
Non-
Glomerulonephritis 
Glomerulonephritis 1.2415 
(0.8544 to 1.8042) 
0.0002 
 
 
  
Table 4-15.   Recipient characteristics associated with a preemptive kidney 
transplantation with employment and Medicare A and B as primary payer and/or 
Medicare as a secondary payer included in the model. 
 
 
Variable 
Reference 
 Group 
Odds Ratio 
(95% CI) 
 
P value 
Age 40 to 55 Age > 55 0.999 
(0.995 to 1.003) 
0.0122 
Black White 0.460 
(0.403 to 0.526) 
<.0001 
Female Male 1.142 
(1.042 to 1.252 
0.0044 
Not-Hypertension Hypertension 3.003 
(2.598 to 3.541) 
<.0001 
Not-Diabetes Diabetes 2.354 
(2.120 to 2.615 
<.0001 
Not-
Glomerulonephritis 
Glomerulonephritis 2.733 
(2.391 to 3.125) 
<.0001 
Employed         Not-Employed 1.133 
(1.024 to 1.254) 
0.0153 
HMO and other  Medicare A and B 
only 
2.204 
(1.966 to 2.471) 
<.0001 
HMO and other Medicare Secondary 1.800 
(1.610 to 2.013) 
<.0001 
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diabetes and glomerulonephritis, reflecting the statistically significant relationships they had 
with PKT in the two aforementioned analyses.  Employment did not show a statistically 
significant relationship and appears to have no direct effect on whether blacks or whites 
receive PKT.  However, insurance, both Medicare A and B and Medicare as a secondary 
payer did show statistical significance.  The interpretation of the statistical significance of 
insurance is that those not covered by Medicare A and B are almost more than twice as likely 
to receive a PKT as those covered by Medicare A and B.  Those not covered by Medicare as 
a secondary payer were more than 80% more likely to receive a PKT as those covered by 
Medicare A and B.  This finding is supported in reflecting back on the subset used to develop 
the cohort analyzed in Table 4-14.  There were only 847 patients identified from the overall 
cohort of 10,067 (8.4%) identified as those on Medicare A and B insurance.  Of those 847 
patients identified in the subset there were 43 black PKT recipients which constituted 5.08% 
of those on Medicare A and B only, but .03% of the overall cohort.   
 When these five independent predictors of receiving a PKT in the analysis of the full 
cohort, (Table 4-14) were included: black race ( [OR] = 0.46, reference: white, i.e., whites 
46% greater odds to receive a PKT than blacks); female (OR =1.16 reference: male; i.e., 
females 16% more likely to receive a preemptive kidney transplant than males); non-
hypertensive (OR = 3.25, reference: hypertension) those without hypertension as the primary 
cause of ESRD were more than 3 times more likely to receive a PKT); non-diabetics (OR = 
2.45, reference: diabetes), those without diabetes as the primary cause of ESRD were more 
than 2 time more likely to receive a PKT; non-glomerulonephritis (OR =2.82; reference: 
Glomerulonephritis,  those without glomerulonephritis as the primary cause of ESRD were 
more than 2 times more likely to receive a PKT). 
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 Subsequent analysis limiting the scope to a subset of the overall cohort to those who 
had Medicare A and B insurance (Table 4-14) only produced similar results to the analysis 
of the overall cohort.  Race, diabetes, hypertension and glomerulonephristis remained 
statistically significant. A final analysis of the overall cohort that also included employment 
and Medicare A and B as the primary insurance and those who had Medicare as a secondary 
payer (Table 4-15) also produced similar results in that race remained significant as did 
diabetes, hypertension and glomerulonephritis.  Employment, was also statistically 
significant in its relationship or a predictor of whether someone receives a PKT.  Medicare A 
and B as the primary insurance and those who had Medicare as a secondary payer each did 
reflect statistical significance as indicators of being less likely for those patients with 
Medicare A and B and/or those patients with Medicare as a secondary insurance to receive a 
PKT.  
The overall hypothesis of this research is that the distribution of PKT is not equitable 
and this inequity is to the detriment of blacks.  First, as this research points out there are clear 
differences between blacks and whites in PKT rates.  Secondly and most importantly this 
research demonstrates that not only are there differences but that a true disparity exist in the 
allocation of PKT between blacks and whites.  Thus this research indicates that the leading 
causes of ESRD in blacks and whites who received PKTs was diabetes (22%) and (31%) 
respectively. Black conventional transplant recipients had higher rates of hypertension and 
diabetes than did black PKT recipients overall. White conventional kidney transplant 
recipients had the highest rates of diabetes (39.19%) of all groups. Of all PKT recipients 
blacks received 10.76% compared to 89.24% received by whites. The mean age for blacks 
receiving PKTs was 48.4 years of age compared to 47 years of age for black conventional 
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 kidney transplant recipients. The mean age for whites, both PKT and conventional transplant 
recipients was approximately 49 years of age. Higher percentages of PKTs took place in the 
northeastern and southeastern regions (UNOS regions 2 and 3) of the United States.  The 
majority of PKT recipients (both blacks and whites) received their donor organs from whites.  
Blacks received 69.42% white donor organs compared to 77.61% received by whites.  Blacks 
did receive 17.43% of their donor organs from blacks, with whites receiving approximately 
6% of their organs from blacks. For those receiving PKTs during the study period, 86% of 
whites and 81% of blacks were alive with functioning grafts. 
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CHAPTER 5.  CONCLUSION 
 
 There remain unexplained differences between blacks and whites in receiving both 
PKT and non-PKT.  It has been suggested that these differences may be the result of 
institutional racism. Indeed the Institute of Medicine concluded in its recent report on the 
racial and ethnic disparities in health care that “although a myriad sources contribute to these 
disparities, some evidence suggests that bias, prejudice, and stereotyping on the part of health 
care providers may contribute to differences in care” (IOM, 2002). 
 From this analysis it is concluded that a disparity does exist in the allocation of PKTs 
between blacks and whites.  This research advances this body of literature in that it narrows 
the scope of the 2002 work of Kasiske, et al. to focus on cadaver donor kidneys, which 
exposes the vulnerabilities of the UNOS waiting list in its roll in the allocation of cadaver 
donor kidneys and at the same time serves to highlight the problems with the kidney 
evaluation process.  Most importantly, this research serves to clearly articulate the disparity 
between blacks and whites in the allocation of PKTs.  Above and beyond other research that 
included both living and cadaver kidneys in their analysis, this research focused on cadavers 
only and instead of limiting the scope to pointing out difference and odds ratio relating to 
those differences in this research access was controlled for by limiting the analysis to those 
with Medicare A and B only and still being able to identify the statistical significance of race.  
This analysis, by controlling for access, was able to state emphatically that there is disparity 
in the allocation of PKT between blacks and whites. This disparity reflects an inequality in 
the allocation of cadaver kidneys.   
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 In the United States, we believe that health care should be fairly distributed by race, 
ethnicity, socioeconomic status, or geographic location. When unfair differences exist, they 
are referred to as disparities. It is important to understand that differences in race and 
ethnicity will always exist; it is wrong, however, when these differences lead to unequal care. 
The specter of health disparities represents an egregious failure of the medical community in 
the United States (Young & Kew, 2005).  Despite the unprecedented explosion in scientific 
knowledge relating to kidney transplantation and the phenomenal capacity of the transplant 
process and the immunosuppression medications to balance the matching issues related to 
kidney transplants, blacks have not benefited fully or equitably from the fruits of this science 
or from those systems responsible for the equitable allocation of cadaver kidneys. Despite the 
efforts here and in other research, the reasons for the disparities in both PKT and 
conventional kidney transplant recipients are not fully understood.  It is likely, however, that 
the complete picture incorporates a complex interaction between socio-cultural, genetic, and 
environmental factors. As reflected in Fig. 5-1, the IOM (2003) identifies the operation of the 
health care system, the legal and regulatory climate in which health care takes place, and/or  
the biases and prejudices that come with discrimination, prejudice, and stereotyping, and 
factors that may contribute to the disparities reflected in PKT and other health care dynamics. 
 In this country, blacks are much less likely than whites to be referred to nephrologists 
and undergo renal transplantation in a timely manner (Kausz, et al., 2000).  Race has 
historically been a factor that is reflected in the literature as having an influence on access to 
general health care in the United States.  Non-minorities enjoy a better quality of health care 
than do minorities.  In trying to understand disparities a spectrum of possibilities offers 
possible explanations.  Disparities between minorities and non-minorities may be the 
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Figure 5-1. Differences, disparities, and discrimination: Populations with equal access 
to health care.   
 
Source: Smedley, I., Stith, B.D., Nelson, A.R. Institute of Medicine (U.S.). Unequal 
Treatment Committee on Understanding and Eliminating Racial and Ethnic Disparities in 
Health Care. National Academies Press, 2003.  Reprinted with permission. 
 
 
 
unintended consequences of the operation of the health care system and the legal and 
regulatory climate or it may be as a result of discriminatory bias or stereotyping (Fig. 5-1).  
 The discrepancy between blacks and whites with respect to PKT is multifaceted and 
is influenced by several factors that dictate how the PKT and conventional transplant process 
unfolds.  It is disparities like those outlined in this research and others that prompted 
Congress to request an Institute of Medicine (IOM) study committee to assess differences in 
the kinds and quality of health care received by minorities when compared to non-minorities.  
While the study committee did not focus specifically on PKT or conventional kidney 
transplantation they did define disparities in health care as racial or ethnic differences in the 
quality of health care that are not due to access related factors or clinical needs, preferences, 
and appropriateness of intervention.  The committee’s analysis was focused at two levels: 1) 
the operation of health care systems and the legal and regulatory climate in which health 
systems function; and 2) discrimination at the individual, patient-provider level.  
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Discrimination, as the committee uses the term, refers to differences in care that result from 
biases, prejudices, stereotyping, and uncertainty in clinical communication and decision-
making (Smedley, Stith, & Nelson, 2003).  While discrimination at the patient level can 
never be dismissed, a type of discrimination that is more subtle is institutional discrimination.  
This refers to policies, procedures, and practices that may appear to be neutral, but the end 
result is uneven access by group membership to resources, status and power (IOM, 2003).  It 
is the perspective of this research that the systemic failures of the health care system and 
lesions in the health policy, legal and regulatory climate that contribute significantly to the 
disparities in the allocation of PKT between blacks and whites. 
 Despite the lower percentages of black patients in this study receiving PKT and the 
lower percentages of PKT reflected in other research, Weng and Mange (2003) indicated that 
patients who underwent the PKT evaluation process overwhelmingly (75%) indicated a 
desire to receive a transplant before initiation of maintenance dialysis.  This was consistent 
with their stated negative impressions of their anticipated quality of life on dialysis.  
However, despite the preferences expressed by these patients and the commencement of the 
transplant evaluation process preemptively, the disparity in PKTs for blacks still exists. 
Although this disparity may stem from the complexity of modern medical care, which 
requires access to physicians, proper diagnosis of renal disease, comprehension by the patient 
of their disease, and referral to a nephrologists and then to a transplant center (Weng & 
Mange, 2003) PKT remains a preferred option that requires that the transplant evaluation 
occur preemptively.   
 Correcting any inequities in PKT will no doubt require substantial effort on the part 
of those who care for patients with kidney disease, and especially those who refer them for 
  87 
 
transplant evaluation (Kasiske et al., 2002).  One critical element in addressing PKT is to 
ensure black patients are referred to nephrologists and transplant centers relatively early in 
the course of progressive renal disease (Kausz, et al., 2001), because late referral to 
nephrology care, when the need for renal replacement therapy is imminent, is associated with 
increased mortality rates (Stack, 2003) and decreased rates of PKT and conventional 
transplants.  Individuals can only be evaluated with sufficient lead-time to undergo PKT if 
patients as well as physicians are educated about the detection and recognition of 
asymptomatic renal disease and the benefits of early referral to a nephrologist.  This will 
require more extensive education about utilizing valid formulae to provide an age, gender 
and race adjusted estimated GFR. (Mange & Weir, 2003). Nephrologists should discuss the 
advantages of PKT with the patients and advocate that these individuals present to a 
transplant center for evaluation, even at the expense of diminishing the nephrologists’ 
dialysis population and subsequent reimbursement for providing dialysis care (Ayanian, et 
al., 1999).   
 As this research points out, individuals with primary causes of ESRD, such as 
diabetes and hypertension were significantly less likely to receive a PKT.  Diabetes and 
especially hypertension tend to affect blacks at higher rates and promote ESRD.  The rate at 
which blacks develop CKD and ultimately reach ESRD will most certainly not change unless 
the medical community can educate blacks and other minorities on how to take charge of 
their health by adopting healthy lifestyles that are likely to ameliorate the tendency toward 
obesity, diabetes, and hypertension.  As the results of this research reflects, for blacks 
diabetes is the underlying cause of ESRD for 22% of all PKT transplant recipients and 34% 
of all conventional transplant recipients.  Hypertension was the primary cause of ESRD for 
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19% of all PKT and 32% of all black conventional kidney transplant recipients.  These 
results support other research that indicated that diabetes and/or hypertension was the 
primary cause of ESRD in 70% of all new ESRD cases (Young and Kew, 2005).  Diabetes is 
nearly 50% more prevalent in blacks than in whites and the pattern of hypertension among 
blacks in the U.S. is unique and remains the leading cause of ESRD for all ages.  Odds ratios 
from this research show that those without diabetes or hypertension as the primary cause of 
their ESRD are 2 and 3 times, respectively, higher odds of getting a PKT.  Based on these 
primary causes of ESRD the likelihood of receiving a PKT for blacks is diminished 
significantly.  In order to change the downstream possibilities of increasing the rates at which 
blacks receive PKT the cormobid conditions that are shown to diminish the likelihood of 
receiving a PKT must be addressed.   This research says that independent of these disease 
states, being black also affects whether an ESRD patient will receive a PKT or not. 
  
DISPARITIES IN PKT, UNOS, AND THE HEALTH POLICY IMPLICATIONS 
 The UNOS waiting list was designed as a just and equitable system through which a 
limited number of organs are allocated to the thousands of Americans in need of a transplant.  
People on the waiting list continue to trust the system because of the belief that everyone on 
the list has an equal opportunity to receive a kidney and that allocation is blind to practices 
and policies that have the potential to be exploited.  Policies that allow or permit the 
manipulation of the waiting list in any way are not only unethical but challenge the integrity 
of the UNOS system (Zink, et al., 2005).  Preemptive transplantation when someone has not 
spent a significant amount of time on the waiting list is either a direct contradiction of the 
clearly articulated UNOS policy that one accumulates points for time on the waiting list or a 
  89 
 
practice that is carried out under the guise of a policy variance, alternative allocation or 
distribution exception, or what is identified as the committee-sponsored alternative system 
provisions of the UNOS policies. Such options within the organ allocation policies are in 
theory designed for the purpose of increasing organ availability and/or organ quality, and 
allowing the latitude to subjectively reduce or address an inequity in organ 
allocation/distribution unique to the local area, and/or examining a policy variation intended 
to benefit the allocation/distribution system overall.  
 As this research has shown, virtually all the preemptive kidney recipients experience 
a lapse time of one day from their first ESRD service and transplantation. While this does not 
automatically mean that these individuals spent less time on the waiting list than all other 
potential recipients, it does lend itself to the possibility that significant numbers of pre-
dialysis patients are being placed on the waiting list earlier and more often in certain regions 
of the country than in others.   
 The UNOS organ allocation protocols have numerous shortcomings and as a result of 
the demand for a scarce resource continues to grow those waiting become desperate and look 
for ways to circumvent policies that govern the waiting list.  It could be argued, this is what 
is being done in order to get the population for preemptive kidney transplants.  By 
subjectively placing patients on the waiting list at various stages of renal failure the process 
of organ allocation will remain inequitable.  In a system with such limited resources, an 
advantage obtained by one person directly causes the disadvantage of another (Zink, et al., 
2005).  
 UNOS and the medical community have agreed that the most effective and ethical 
way to allocate organs is through a balance of the principles of equity and utility.  According 
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to the principle of equity as outlined by Zink, et al., (2005) once placed on the UNOS waiting 
list, every member of the list should have an equal chance of receiving a much needed organ.   
Allocation of organs through the principles of utility should result in the prioritization of 
organs to the best candidates in the most need (Zink et al., 2005).  Striking the balance 
between the two principles can never be done through the subjective application of the 
UNOS policies currently in effect. Practices such as solicitation for organs, directed 
donation, multiple listing or preemptive kidney transplantation were never intended to allow 
people to gain an unfair advantage.  Regardless of the intent of such practices each of them 
has inherent within it the potential for abuse.  
  In 2003, UNOS modified the allocation algorithm to eliminate points for HLA 
matching but continues to allow for local variances based on the concept of acceptable 
mismatches that at least theoretically, preserve the benefits of matching while offering more 
equitable allocation (Takemoto, et al., 2000).  In light of the increasing recognition of the 
influence of non-immunologic factors on long time survival, this is yet another opportunity 
for the subjective abuse of the organ allocation decision making process.  Given all the 
subjective latitude built into the allocation policies it may be time to formulate a completely 
new paradigm for organ allocation. 
 
FUTURE RESEARCH CONSIDERATIONS  
 The continued examination of UNOS policies is an absolute necessity in ongoing 
efforts to ensure the just and equitable allocation of kidneys and for a system to avoid the 
exploitation by those who are forced to resort to desperate measures during desperate times.  
The growing gap between the demand for lifesaving organs and their availability as reflected 
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during this study leaves thousands waiting for an organ and thousands more to die before a 
kidney can be allocated to them.  Hence the compelling need to improve the system of organ 
procurement and allocation   Socioeconomic status is routinely identified in the literature as 
having an impact on whether someone gets kidney transplant or not (Young & Kew, 2005). 
Although a significant number of poorer members of the majority population are clearly 
present in all parts of the United States, the number of blacks with incomes below the federal 
poverty level is fourfold greater than the number of whites at this level (Young & Kew, 
2005).  As a result, blacks are much more likely to be dependent on public assistance 
programs such as Medicare and Medicaid for health insurance and medication coverage.  As 
Kasiske, et al. (2002) pointed out in their study the primary source of payment was the 
strongest correlate of PKT.  Kasiske’s research supports (Table 4-15) that patients who had 
Medicare as the primary payer or as a secondary payer were much less likely to receive 
preemptive transplants.  
 Kasiske’s study (2002) as does this study conceded the point that it was probable 
Medicare may be a surrogate for other socioeconomic factors.  As the authors go on to point 
out that even though Medicare may eventually cover the cost of transplantation, the 
significant expenses that may be incurred before qualifying for Medicare may be prohibitive 
for may patients who could otherwise be candidates for PKT.  In another study Kasiske, et al. 
(1998) points out those patients who have suboptimal insurance coverage may be more likely 
to fail to keep initial appointments with the transplant center, due to concerns about cost and 
payment.  According to Kasiske et al. (1998) others have found that race and socioeconomic 
factors influence health care utilization even when there is adequate insurance coverage 
(Gornick, et al., 1996).  As pointed out in this research, when insurance coverage is equal 
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(Table 4-15) race and perhaps unidentified socioeconomic factors and institutional systems 
still lead to differences in PKT rates.  Overcoming socioeconomic barriers to health care is 
not simply a matter of insurance coverage. Given that Medicare covers the cost of 
transplantation, preemptive and conventional, it is possible that removing the pre-transplant 
disincentives by expanding Medicare coverage to make PKT more accessible to those limited 
to Medicare coverage that blacks may experience increased PKT rates.  Further evaluation of 
the impact of Medicare on the ESRD population specifically relating to receipt of PKT needs 
to be undertaken.  
 The benefits of PKT are well documented in the literature; however, the benefits of 
PKT are not shared equally among transplant recipients. This research validates the 
perceptions of the inequities in the allocation of both preemptive and conventional cadaver 
kidney transplants. This validation of that perception of inequity threatens the very 
foundation upon which our system of altruistic organ donation is built.  In a global society 
that prides itself on a high level of sensitivity and equality, there is an ethical and moral 
imperative to address the continuing racial/ethnic disparities in PKT and the many factors 
that are potentially underlying this disparity.  Given the rising demand for kidney 
transplantation within a setting of scarce resources, the economic and ethical dimensions of 
transplant medicine are of increasing interest and importance to patients, providers and 
payers.  Continued research in this area focusing on health policy and practice adaptations 
will assist in uncovering ways to maximize use of PKT in an ethical and cost-effective 
manner that ultimately results in reduced cost to the ESRD program and the prolonging and 
improvement in the quality of many lives.  A specific example would be primary care policy 
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changes mandating the screening of hypertensive blacks for declining kidney function so that 
priority consideration could be given for PKT. 
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